Skip to main content

Carlyle Group Inc.

For the period ended Mar 31, 2025. Filed May 9, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 9, 2025

CG$42.31+6.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to the Condensed Consolidated Financial Statements

  1. Organization

Carlyle is one of the world’s largest global investment firms that deploys private capital across its business and conducts

its operations through three reportable segments: Global Private Equity, Global Credit, and Carlyle AlpInvest (see Note 15,

Segment Reporting). In the Global Private Equity segment, Carlyle advises buyout, growth, real estate, infrastructure, and

natural resources funds. The Global Private Equity segment also includes the NGP Carry Funds advised by NGP. The Global

Credit segment advises funds and vehicles that pursue investment strategies including insurance solutions, liquid credit,

opportunistic credit, direct lending, asset-backed finance, aviation finance, infrastructure credit, cross-platform credit products,

and global capital markets. The Carlyle AlpInvest segment (formerly, Global Investment Solutions) advises global private

equity programs that pursue secondary purchases and financing of existing portfolios, managed co-investment programs, and

primary fund investments. Carlyle typically serves as the general partner, investment manager or collateral manager, making

day-to-day investment decisions concerning the assets of these products.

  1. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements are prepared in accordance with accounting principles

generally accepted in the United States (“U.S. GAAP”) and include the accounts of the Company and its consolidated

subsidiaries. In addition, certain Carlyle-affiliated funds, related co-investment entities and certain CLOs managed by the

Company (collectively, the “Consolidated Funds”) have been consolidated in the accompanying financial statements. The

consolidation of the Consolidated Funds generally has a gross-up effect on assets, liabilities and cash flows, and generally has

no effect on the net income attributable to the Company. The economic ownership interests of the other investors in the

Consolidated Funds are reflected as non-controlling interests in consolidated entities in the accompanying condensed

consolidated financial statements. All of the investments held and notes issued by the Consolidated Funds are presented at their

estimated fair values in the Company’s condensed consolidated balance sheets. Interest and other income of the Consolidated

Funds, interest expense and other expenses of the Consolidated Funds, and net investment income (losses) of Consolidated

Funds are included in the Company’s condensed consolidated statements of operations.

Management has determined that the Company’s funds are investment companies under U.S. GAAP for the purposes

of financial reporting. U.S. GAAP for an investment company requires investments to be recorded at estimated fair value and

the unrealized gains and/or losses in an investment’s fair value are recognized on a current basis in the statements of operations.

Additionally, the funds do not consolidate their majority-owned and controlled investments (the “Portfolio Companies”). In the

preparation of these condensed consolidated financial statements, the Company has retained the specialized accounting for the

funds.

The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for

interim financial information. These statements, including notes, have not been audited, exclude some of the disclosures

required for annual financial statements, and should be read in conjunction with the audited consolidated financial statements

included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities

and Exchange Commission (“SEC”) on February 27, 2025. The operating results presented for interim periods are not

necessarily indicative of the results that may be expected for any other interim period or for the entire year. In the opinion of

management, the condensed consolidated financial statements reflect all adjustments, consisting of normal recurring accruals,

which are necessary for the fair presentation of the financial condition and results of operations for the interim periods

presented.

Principles of Consolidation

The Company consolidates all entities that it controls either through a majority voting interest or as the primary

beneficiary of variable interest entities (“VIEs”).

The Company evaluates (1) whether it holds a variable interest in an entity, (2) whether the entity is a VIE, and (3)

whether the Company’s involvement would make it the primary beneficiary. In evaluating whether the Company holds a

variable interest, fees (including management fees, incentive fees and performance allocations) that are customary and

commensurate with the level of services provided, and where the Company does not hold other economic interests in the entity

that would absorb more than an insignificant amount of the expected losses or returns of the entity, are not considered variable

interests. The Company considers all economic interests, including indirect interests, to determine if a fee is considered a

variable interest.

For those entities where the Company holds a variable interest, the Company determines whether each of these entities

qualifies as a VIE and, if so, whether or not the Company is the primary beneficiary. The assessment of whether the entity is a

VIE is generally performed qualitatively, which requires judgment. These judgments include: (a) determining whether the

equity investment at risk is sufficient to permit the entity to finance its activities without additional subordinated financial

support, (b) evaluating whether the equity holders, as a group, can make decisions that have a significant effect on the economic

performance of the entity, (c) determining whether two or more parties’ equity interests should be aggregated, and (d)

determining whether the equity investors have proportionate voting rights to their obligations to absorb losses or rights to

receive returns from an entity.

For entities that are determined to be VIEs, the Company consolidates those entities where it has concluded it is the

primary beneficiary. The primary beneficiary is defined as the variable interest holder with (a) the power to direct the activities

of a VIE that most significantly impact the entity’s economic performance and (b) the obligation to absorb losses of the entity

or the right to receive benefits from the entity that could potentially be significant to the VIE. In evaluating whether the

Company is the primary beneficiary, the Company evaluates its economic interests in the entity held either directly or indirectly

by the Company.

As of March 31, 2025, assets and liabilities of the consolidated VIEs reflected in the condensed consolidated balance

sheets were$10.1 billion and$8.8 billion, respectively. As of December 31, 2024, assets and liabilities of the consolidated

VIEs reflected in the consolidated balance sheets were$8.9 billion and$7.7 billion, respectively. Except to the extent of the

consolidated assets of the VIEs, the holders of the consolidated VIEs’ liabilities generally do not have recourse to the Company.

The Company’s Consolidated Funds are primarily CLOs, which are VIEs that issue loans payable that are backed by

diversified collateral asset portfolios consisting primarily of loans or structured debt. In exchange for managing the collateral

for the CLOs, the Company earns investment management fees, including in some cases subordinated management fees and

contingent incentive fees. In cases where the Company consolidates the CLOs (primarily because of a retained interest that is

significant to the CLO), those management fees and contingent incentive fees have been eliminated as intercompany

transactions. As of March 31, 2025, the Company held$329.3 million of investments in these CLOs which represents its

maximum risk of loss. The Company’s investments in these CLOs are generally subordinated to other interests in the entities

and entitle the Company to receive a pro rata portion of the residual cash flows, if any, from the entities. Investors in the CLOs

have no recourse against the Company for any losses sustained in the CLO structure. The Company’s Consolidated Funds also

include certain investment funds in the Global Private Equity segment that are accounted for as consolidated VIEs due to the

Company providing financing to bridge investment purchases. As of March 31, 2025, the Company held$663.6 million of

notes receivable and investments related to these investment funds which represents its maximum risk of loss. The Company’s

Consolidated Funds also include certain funds in the Global Credit and Carlyle AlpInvest segments that are accounted for as

consolidated VIEs due to the Company having a significant indirect interest in these funds via the Company’s investment in

Fortitude (see Note 4, Investments).

Entities that do not qualify as VIEs are generally assessed for consolidation as voting interest entities. Under the voting

interest entity model, the Company consolidates those entities it controls through a majority voting interest.

All significant inter-entity transactions and balances of entities consolidated have been eliminated.

Investments in Unconsolidated Variable Interest Entities

The Company holds variable interests in certain VIEs that are not consolidated because the Company is not the primary

beneficiary, including its investments in certain credit vehicles and certain AlpInvest vehicles, as well as its strategic investment

in NGP Management Company, L.L.C. (“NGP Management” and, together with its affiliates, “NGP”). Refer to Note 4,

Investments, for information on the strategic investment in NGP. The Company’s involvement with such entities is in the form

of direct or indirect equity interests and fee arrangements. The maximum exposure to loss represents the loss of assets

recognized by the Company relating to its variable interests in these unconsolidated entities.

The assets recognized in the Company’s condensed consolidated balance sheets related to the Company’s variable

interests in these non-consolidated VIEs were as follows:

As of
March 31, 2025December 31, 2024
(Dollars in millions)
Investments$836.0$942.6
Accrued performance allocations640.2580.8
Management fee receivables70.762.4
Total$1,546.9$1,585.8

These amounts represent the Company’s maximum exposure to loss related to the unconsolidated VIEs as of March 31,

2025 and December 31, 2024.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make assumptions and

estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of

the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting

period. Management’s estimates are based on historical experiences and other factors, including expectations of future events

that management believes to be reasonable under the circumstances. It also requires management to exercise judgment in the

process of applying the Company’s accounting policies. Assumptions and estimates regarding the valuation of investments and

their resulting impact on performance allocations and incentive fees involve a higher degree of judgment and complexity and

these assumptions and estimates may be significant to the condensed consolidated financial statements and the resulting impact

on performance allocations and incentive fees. Actual results could differ from these estimates and such differences could be

material.

Revenue Recognition

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. Revenue is

recognized when the Company transfers promised goods or services to customers in an amount that reflects the consideration to

which the Company expects to be entitled in exchange for those goods or services. ASC 606 includes a five-step framework

that requires an entity to: (i) identify the contract(s) with a customer, which includes assessing the collectability of the

consideration to which it will be entitled in exchange for the goods or services transferred to the customer, (ii) identify the

performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the

performance obligations in the contract, and (v) recognize revenue when the entity satisfies a performance obligation.

The Company accounts for performance allocations that represent a performance-based capital allocation from fund

limited partners to the Company (commonly known as “carried interest”) as earnings from financial assets within the scope of

ASC 323, Investments—Equity Method and Joint Ventures, and therefore are not in the scope of ASC 606. In accordance with

ASC 323, the Company records equity method income (losses) as a component of investment income based on the change in its

proportionate claim on net assets of the investment fund, including performance allocations, assuming the investment fund was

liquidated as of each reporting date pursuant to each fund’s governing agreements. See Note 4, Investments, for additional

information on the components of investments and investment income. Performance fees that do not meet the definition of

performance-based capital allocations are in the scope of ASC 606 and are included in incentive fees in the condensed

consolidated statements of operations. The calculation of unrealized performance revenues utilizes investment valuations of the

funds’ underlying investments, which are derived using the policies, methodologies and templates prepared by the Company’s

valuation group, as described in Note 3, Fair Value Measurement.

While the determination of who is the customer in a contractual arrangement will be made on a contract-by-contract

basis, the customer will generally be the investment fund for the Company’s significant management and advisory contracts.

The customer determination impacts the Company’s analysis of the accounting for contract costs.

Fund Management Fees

The Company provides management services to funds in which it holds a general partner interest or to funds or certain

portfolio companies with which it has an investment advisory or investment management agreement. The Company considers

the performance obligations in its contracts with its funds to be the promise to provide (or to arrange for third parties to provide)

investment management services related to the management, policies and operations of the funds.

As it relates to the Company’s performance obligation to provide investment management services, the Company

typically satisfies this performance obligation over time as the services are rendered, as the funds simultaneously receive and

consume the benefits provided as the Company performs the service. The transaction price is the amount of consideration to

which the Company expects to be entitled in exchange for transferring the promised services to the funds. Management fees

earned from each investment management contract over the contract life represent variable consideration because the

consideration the Company is entitled to varies based on fluctuations in the basis for the management fee, for example fund net

asset value (“NAV”) or assets under management (“AUM”). Given that the management fee basis is susceptible to market

factors outside of the Company’s influence, management fees are constrained and, therefore, estimates of future period

management fees are generally not included in the transaction price. Revenue recognized for the investment management

services provided is generally the amount determined at the end of the period because that is when the uncertainty for that

period is resolved.

For closed-end carry funds in the Global Private Equity segment, management fees generally range from 1.0% to 2.0% of

limited partners’ capital commitments during the fund’s commitment period. For closed-end carry funds in the Global Credit

segment, management fees generally range from 1.0% to 2.0% of limited partners’ invested capital. Following the expiration or

termination of the investment period, management fees generally are based on the lower of cost or fair value of invested capital

and the rate charged may also be reduced. These terms may vary for certain separately managed accounts, longer-dated carry

funds, and other closed-end funds. The Company will receive management fees during a specified period of time, which is

generallyten years from the initial closing date, or, in some instances, from the final closing date, but such termination date

may be earlier in certain limited circumstances or later if extended for successiveone-year periods, typically up to a maximum

oftwo years. Depending upon the contracted terms of investment advisory or investment management and related agreements,

these fees are generally called semi-annually in advance and are recognized as earned over the subsequentsix month period.

For certain longer-dated carry funds and certain other closed-end funds, management fees are called quarterly over the life of

the funds.

Within the Global Credit segment, for CLOs and other structured products, management fees generally range from 0.4%

to 0.5% based on the total par amount of assets or the aggregate principal amount of the notes in the CLO and are generally due

quarterly in arrears based on the terms and recognized over the respective period. Management fees for the CLOs and other

structured products are governed by indentures and collateral management agreements. The Company will receive management

fees for the CLOs, generally five toten years after issuance, including after the CLO redemption date until all eligible assets are

disposed of or at such time the collateral manager waives fees at its discretion. Management fees for the business development

companies are due quarterly in arrears at annual rates that range from 1.0% of capital under management to 1.5% of gross

assets, excluding cash and cash equivalents. Management fees for CTAC are due monthly in arrears at the annual rate of 1.0%

of the month-end value of the CTAC’s net assets. Carlyle Aviation Partners’ funds have varying management fee arrangements

depending on the strategy of the particular fund. Under the strategic advisory services agreement with Fortitude, the Company

earns a recurring management fee based on Fortitude’s general account assets, which adjusts within an agreed upon range based

on Fortitude’s overall profitability and is due quarterly in arrears. Management fees for certain of our perpetual capital

strategies and separately managed accounts in Global Credit have annual rates that generally range from 0.10% to 0.75%, which

are charged based on invested capital or the fair value of the underlying assets, though management fee arrangements vary

depending on the strategy of the particular account.

Management fees for the Company’s carry fund vehicles in the Carlyle AlpInvest segment generally range from 0.25% to

1.5% of the vehicle’s capital commitments during the commitment fee period of the relevant fund. Following the expiration of

the commitment fee period, the management fees generally range from 0.25% to 1.5% on (i) the net invested capital, (ii) the

lower of cost or net asset value of the capital invested, or (iii) the net asset value for unrealized investments. Management fees

for the Carlyle AlpInvest carry fund vehicles are generally due quarterly in advance and recognized over the related quarter.

The investment advisers to the CAPM funds are entitled to receive a monthly management fee equal to 1.25% on an annualized

basis of the fund’s net asset value as of the last day of the month.

The Company also provides transaction advisory and portfolio advisory services to the portfolio companies, and where

covered by separate contractual agreements, recognizes fees for these services when the performance obligation has been

satisfied and collection is reasonably assured. The Company is generally required to offset its fund management fees earned

from the funds that have invested in the portfolio companies to which the service has been provided by a percentage of the

transaction and advisory fees allocable to those funds. This amount is referred to as the “rebate offset,” and is generally 100%.

Transaction and advisory fees allocable to funds that do not pay fund management fees do not have a rebate offset. The

Company also recognizes underwriting fees from the Company’s loan syndication and capital markets business, Carlyle Global

Capital Markets. Fund management fees include transaction and portfolio advisory fees, as well as capital markets fees, of

$76.7 million and$23.8 million for thethree months ended March 31, 2025 and 2024, respectively, net of rebate offsets as

defined in the respective fund limited partnership agreements.

Fund management fees exclude the reimbursement of any partnership expenses paid by the Company on behalf of the

Carlyle funds pursuant to the limited partnership agreements, including amounts related to the pursuit of actual, proposed, or

unconsummated investments, professional fees, expenses associated with the acquisition, holding and disposition of

investments, and other fund administrative expenses. For the professional fees that the Company arranges for the investment

funds, the Company concluded that the nature of its promise is to arrange for the services to be provided and it does not control

the services provided by third parties before they are transferred to the customer. Therefore, the Company concluded it is acting

in the capacity of an agent. Accordingly, the reimbursement for these professional fees paid on behalf of the investment funds is

presented on a net basis in general, administrative and other expenses in the condensed consolidated statements of operations.

The Company also incurs certain costs, primarily employee travel and entertainment costs, employee compensation and

systems costs, for which it receives reimbursement from the investment funds in connection with its performance obligation to

provide investment and management services. For reimbursable travel, compensation and systems costs, the Company

concluded it controls the services provided by its employees and the resources used to develop applicable systems before they

are transferred to the customer and therefore is a principal. Accordingly, the reimbursement for these costs incurred by the

Company to manage the fund limited partnerships are presented on a gross basis in interest and other income in the condensed

consolidated statements of operations and the expense in general, administrative and other expenses or cash-based

compensation and benefits expenses in the condensed consolidated statements of operations.

Incentive Fees

The Company is also entitled to receive performance-based incentive fees when the return on assets under management

exceeds certain benchmark returns or other performance targets. In such arrangements, incentive fees are recognized when the

performance benchmark has been achieved. Incentive fees are variable consideration because they are contingent upon the

investment vehicle achieving stipulated investment return hurdles. Investment returns are highly susceptible to market factors

outside of the Company’s influence. Accordingly, incentive fees are constrained until all uncertainty is resolved. Estimates of

future period incentive fees are generally not included in the transaction price because these estimates are constrained. The

transaction price for incentive fees is generally the amount determined at the end of each accounting period to which they relate

because that is when the uncertainty for that period is resolved, as these fees are not subject to clawback.

Investment Income (Loss), including Performance Allocations

Investment income (loss) represents the unrealized and realized gains and losses resulting from the Company’s equity

method investments, including any associated general partner performance allocations, and other principal investments,

including CLOs.

General partner performance allocations consist of the allocation of profits from certain of the funds to which the

Company is entitled (commonly known as carried interest).

For closed-end carry funds in the Global Private Equity and Global Credit segments, the Company is generally entitled to

a 20% allocation (or approximately 2% to 12.5% for most of the Carlyle AlpInvest segment carry fund vehicles) of the net

realized income or gain as a carried interest after returning the invested capital, the allocation of preferred returns of generally

7% to 9% and return of certain fund costs (generally subject to catch-up provisions as set forth in the fund limited partnership

agreement). These terms may vary on longer-dated funds, certain credit funds, and external co-investment vehicles. Carried

interest is recognized upon appreciation of the funds’ investment values above certain return hurdles set forth in each respective

partnership agreement. The Company recognizes revenues attributable to performance allocations based upon the amount that

would be due pursuant to the fund partnership agreement at each period end as if the funds were terminated at that date.

Accordingly, the amount recognized as investment income for performance allocations reflects the Company’s share of the

gains and losses of the associated funds’ underlying investments measured at their then-current fair values relative to the fair

values as of the end of the prior period. Because of the inherent uncertainty, these estimated values may differ significantly

from the values that would have been used had a ready market for the investments existed, and it is reasonably possible that the

difference could be material.

Carried interest is ultimately realized when: (i) an underlying investment is profitably disposed of, (ii) certain costs borne

by the limited partner investors have been reimbursed, (iii) the fund’s cumulative returns are in excess of the preferred return,

and (iv) the Company has decided to collect carry rather than return additional capital to limited partner investors. Realized

carried interest may be required to be returned by the Company in future periods if the fund’s investment values decline below

certain levels. When the fair value of a fund’s investments remains constant or falls below certain return hurdles, previously

recognized performance allocations are reversed. In all cases, each fund is considered separately in this regard, and for a given

fund, performance allocations can never be negative over the life of a fund. If upon a hypothetical liquidation of a fund’s

investments at their then-current fair values, previously recognized and distributed carried interest would be required to be

returned, a liability is established for the potential giveback obligation. As of March 31, 2025 and December 31, 2024, the

Company accrued$44.6 million and$44.0 million, respectively, for giveback obligations.

Principal investment income (loss) is realized when the Company redeems all or a portion of its investment or when the

Company receives or is due cash income, such as dividends or distributions. Unrealized principal investment income (loss)

results from the Company’s proportionate share of the investee’s unrealized earnings, including changes in the fair value of the

underlying investment, as well as the reversal of unrealized gain (loss) at the time an investment is realized. As it relates to the

Company’s investments in NGP (see Note 4, Investments), principal investment income includes the related amortization of the

basis difference between the Company’s carrying value of its investment and the Company’s share of underlying net assets of

the investee, as well as the compensation expense associated with compensatory arrangements provided by the Company to

employees of its equity method investee, and impairment charges.

Interest Income

Interest income is recognized when earned. For debt securities representing non-investment grade beneficial interests in

securitizations, the effective yield is determined based on the estimated cash flows of the security. Changes in the effective

yield of these securities due to changes in estimated cash flows are recognized on a prospective basis as adjustments to interest

income in future periods. Interest income earned by the Company is included in interest and other income in the accompanying

condensed consolidated statements of operations. Interest income of the Consolidated Funds was$123.0 million and$142.6

million for thethree months ended March 31, 2025 and 2024, respectively, and is included in interest and other income of

Consolidated Funds in the accompanying condensed consolidated statements of operations.

Credit Losses

The Company measures all expected credit losses for financial assets held at the reporting date in accordance with ASC

326, Financial Instruments—Credit Losses, based on historical experience, current conditions, and reasonable and supportable

forecasts. The Company assesses the collection risk characteristics of the outstanding amounts in its due from affiliates balance

into the following pools of receivables:

Reimbursable fund expenses receivables,

Management fee receivables,

Incentive fee receivables,

Transaction fee receivables,

Portfolio fee receivables, and

Notes receivable.

The Company generally utilizes either historical credit loss information or discounted cash flows to calculate expected

credit losses for each pool. The Company’s receivables are predominantly with its investment funds, which have low risk of

credit loss based on the Company’s historical experience. Historical credit loss data may be adjusted for current conditions and

reasonable and supportable forecasts, including the Company’s expectation of near-term realization based on the liquidity of the

affiliated investment funds.

Compensation and Benefits

Cash-Based Compensation and Benefits – Cash-based compensation and benefits includes salaries, bonuses

(discretionary awards and guaranteed amounts), performance payment arrangements and benefits paid and payable to Carlyle

employees. Bonuses are accrued over the service period to which they relate.

Equity-Based Compensation – Compensation expense relating to the issuance of equity-based awards is measured at fair

value on the grant date. The compensation expense for awards that vest over a future service period is recognized over the

relevant service period on a straight-line basis. The compensation expense for awards that do not require future service is

recognized immediately. Cash settled equity-based awards are classified as liabilities and are re-measured at the end of each

reporting period. The compensation expense for awards that contain performance conditions is recognized when it is probable

that the performance conditions will be achieved. The compensation expense for awards that contain market conditions is based

on a grant-date fair value that factors in the probability that the market conditions will be achieved and is recognized over the

requisite service period on a straight-line basis.

Certain equity-based awards contain dividend-equivalent rights, which are subject to the same terms and conditions,

including with respect to vesting and settlement, that apply to the related award. Dividend-equivalents are accounted for as a

reclassification from retained earnings to additional paid-in capital at the time dividends are declared and do not result in

incremental compensation expense.

Equity-based awards issued to non-employees are generally recognized as general, administrative and other expenses,

except to the extent they are recognized as part of the Company’s equity method earnings because they are issued to employees

of equity method investees.

The Company recognizes equity-based award forfeitures in the period they occur as a reversal of previously recognized

compensation expense for awards that vest based on service and/or performance conditions. The reduction in compensation

expense is determined based on the specific awards forfeited during that period. Furthermore, the Company recognizes all

excess tax benefits and deficiencies as income tax benefit or expense in the condensed consolidated statements of operations.

For awards with a market condition (e.g., achievement of certain stock price hurdles) that are forfeited due to the market

condition not being achieved, the related equity-based compensation expense is not reversed.

Performance Allocations and Incentive Fee Related Compensation – A portion of the performance allocations and

incentive fees and certain other interests earned is due to employees and advisors of the Company. These amounts are

accounted for as profit sharing interests in compensation expense in a systematic and rational manner in conjunction with the

recognition of the related performance allocations and incentive fee revenue and, until paid, are recognized as a component of

the accrued compensation and benefits liability. The liability is measured assuming the hypothetical liquidation of the

associated funds’ underlying investments as of the measurement date. Accordingly, upon a reversal of performance allocations

or incentive fee revenue, the related compensation expense, if any, is also reversed. As any vesting requirement is accelerated

upon realization, the service period is not considered substantive when recording the liability based on the hypothetical

liquidation value. As of both March 31, 2025 and December 31, 2024, the Company recorded a liability of$4.8 billion related

to the portion of accrued performance allocations and incentive fees due to employees and advisors, respectively, which was

included in accrued compensation and benefits in the accompanying condensed consolidated balance sheets.

Income Taxes

The Carlyle Group Inc. is a corporation for U.S. federal income tax purposes and thus is subject to U.S. federal, state and

local corporate income taxes. Tax positions taken by the Company are subject to periodic audit by U.S. federal, state, local and

foreign taxing authorities. The interim provision for income taxes is calculated using the discrete effective tax rate method as

allowed by ASC 740, Accounting for Income Taxes. The discrete method is applied when the application of the estimated

annual effective tax rate is impractical because it is not possible to reliably estimate the annual effective tax rate. In addition, the

discrete method treats the year-to-date period as if it was the annual period and determines the income tax expense or benefit on

that basis.

The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred

tax assets and liabilities for the expected future consequences of events that have been included in the financial statements or

tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial

statement reporting and the tax basis of assets and liabilities using enacted tax rates in effect for the period in which the

difference is expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the

period of the change in the provision for income taxes. Further, deferred tax assets are recognized for the expected realization of

available net operating loss and tax credit carry forwards. A valuation allowance is recorded on the Company’s gross deferred

tax assets when it is “more likely than not” that such asset will not be realized. When evaluating the realizability of the

Company’s deferred tax assets, all evidence, both positive and negative, is evaluated. Items considered in this analysis include

the ability to carry back losses, the reversal of temporary differences, tax planning strategies, and expectations of future

earnings. The Company accounts for the valuation allowance assessment on its deferred tax assets and without regard to the

Company’s potential future corporate alternative minimum tax (“CAMT”) status or global minimum tax status under the Pillar

Two Global Anti-Base Erosion (“GloBE”) model rules of the Organization for Economic Co-operation and Development

(“OECD”). Therefore, the Company accounts for CAMT and the global minimum tax in the period as incurred. Lastly, the

Company accounts for the tax on global intangible low-taxed income (“GILTI”) as incurred and therefore has not recorded

deferred taxes related to GILTI on its foreign subsidiaries.

Under U.S. GAAP for income taxes, the amount of tax benefit to be recognized is the amount of benefit that is “more

likely than not” to be sustained upon examination. The Company analyzes its tax filing positions in all of the U.S. federal, state,

local and foreign tax jurisdictions where it is required to file income tax returns, as well as for all open tax years in these

jurisdictions. If, based on this analysis, the Company determines that uncertainties in tax positions exist, a liability is

established, which is included in accounts payable, accrued expenses and other liabilities in the condensed consolidated

financial statements. The Company recognizes accrued interest and penalties related to unrecognized tax positions in the

provision for income taxes. If recognized, the entire amount of unrecognized tax positions would be recorded as a reduction in

the provision for income taxes.

Non-controlling Interests

Non-controlling interests in consolidated entities represent the component of equity in consolidated entities held by third-

party investors. These interests are adjusted for general partner allocations which occur during the reporting period. Any change

in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between

the controlling and non-controlling interests. Transaction costs incurred in connection with such changes in ownership of a

subsidiary are recorded as a direct charge to equity.

Earnings Per Common Share

The Company computes earnings per common share in accordance with ASC 260, Earnings Per Share. Basic earnings

per common share is calculated by dividing net income (loss) attributable to the common shares of the Company by the

weighted-average number of common shares outstanding for the period. Diluted earnings per common share reflects the

assumed conversion of all dilutive securities. The Company applies the treasury stock method to determine the dilutive

weighted-average common shares outstanding for certain equity-based compensation awards. For certain equity-based

compensation awards that contain performance or market conditions, the number of contingently issuable common shares is

included in diluted earnings per common share based on the number of common shares, if any, that would be issuable under the

terms of the awards if the end of the reporting period were the end of the contingency period, if the result is dilutive.

Fair Value of Financial Instruments

The underlying entities that the Company manages and invests in (and in certain cases, consolidates) are primarily

investment companies which account for their investments at estimated fair value.

The fair value measurement accounting guidance under ASC 820, Fair Value Measurement, establishes a hierarchical

disclosure framework which ranks the observability of market price inputs used in measuring financial instruments at fair value.

The observability of inputs is impacted by a number of factors, including the type of financial instrument, the characteristics

specific to the financial instrument and the state of the marketplace, including the existence and transparency of transactions

between market participants. Financial instruments with readily available quoted prices, or for which fair value can be measured

from quoted prices in active markets, will generally have a higher degree of market price observability and a lesser degree of

judgment applied in determining fair value.

Financial instruments measured and reported at fair value are classified and disclosed based on the observability of inputs

used in the determination of fair values, as follows:

Level I– inputs to the valuation methodology are quoted prices available in active markets for identical

instruments as of the reporting date. The type of financial instruments in this category include unrestricted

securities, such as equities and derivatives, listed in active markets. The Company does not adjust the quoted price

for these instruments, even in situations where the Company holds a large position and a sale could reasonably

impact the quoted price.

Level II – inputs to the valuation methodology are other than quoted prices in active markets, which are either

directly or indirectly observable as of the reporting date. The types of financial instruments in this category

include less liquid and restricted securities listed in active markets, securities traded in other than active markets,

government and agency securities, and certain over-the-counter derivatives where the fair value is based on

observable inputs.

Level III – inputs to the valuation methodology are unobservable and significant to overall fair value

measurement. The inputs into the determination of fair value require significant management judgment or

estimation. The types of financial instruments in this category include investments in privately-held entities, non-

investment grade residual interests in securitizations, collateralized loan obligations, and certain over-the-counter

derivatives where the fair value is based on unobservable inputs.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such

cases, the determination of which category within the fair value hierarchy is appropriate for any given financial instrument is

based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the

significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to

the financial instrument.

In certain cases, debt and equity securities (including corporate treasury investments) are valued on the basis of prices

from an orderly transaction between market participants provided by reputable dealers or pricing services. In determining the

value of a particular investment, pricing services may use certain information with respect to transactions in such investments,

quotations from dealers, pricing matrices, market transactions in comparable investments and various relationships between

investments.

In the absence of observable market prices, the Company values its investments and its funds’ investments using

valuation methodologies applied on a consistent basis. For some investments little market activity may exist. Management’s

determination of fair value is then based on the best information available in the circumstances and may incorporate

management’s own assumptions and involve a significant degree of judgment, taking into consideration a combination of

internal and external factors, including the appropriate risk adjustments for non-performance and liquidity risks. Investments for

which market prices are not observable include private investments in the equity and debt of operating companies and real

assets, CLO investments and CLO loans payable and fund investments. The valuation technique for each of these investments is

described below:

Investments in Operating Companies and Real Assets – The fair values of private investments in operating companies

and real assets are generally determined by reference to the income approach (including the discounted cash flow

method and the income capitalization method) and the market approach (including the comparable publicly traded

company method and the comparable transaction method). Valuations under these approaches are typically derived by

reference to investment-specific inputs (such as projected cash flows, earnings before interest, taxes, depreciation and

amortization (“EBITDA”), and net operating income) combined with market-based inputs (such as discount rates,

EBITDA multiples and capitalization rates). In many cases, the investment-specific inputs are unaudited at the time

received. Management may also adjust the market-based inputs to account for differences between the subject

investment and the companies, assets or investments used to derive the market-based inputs. Adjustments to

observable valuation measures are frequently made upon the initial investment to calibrate the initial investment

valuation to industry observable inputs. Such adjustments are made to align the investment to observable industry

inputs for differences in size, profitability, projected growth rates, geography, capital structure, and other factors as

applicable. The adjustments are then reviewed with each subsequent valuation to assess how the investment has

evolved relative to the observable inputs. Additionally, the investment may be subject to certain specific risks and/or

development milestones which are also taken into account in the valuation assessment. Option pricing models and

similar tools may also be considered but do not currently drive a significant portion of operating company or real asset

valuations and are used primarily to value warrants, derivatives, certain restrictions and other atypical investment

instruments.

Credit-Oriented Investments –The fair values of credit-oriented investments (including corporate treasury

investments) are generally determined on the basis of prices between market participants provided by reputable dealers

or pricing services. In determining the value of a particular investment, pricing services may use certain information

with respect to transactions in such investments, quotations from dealers, pricing matrices, market transactions in

comparable investments and various relationships between investments. Specifically, for investments in distressed debt

and corporate loans and bonds, the fair values are generally determined by valuations of comparable investments. In

some instances, the Company may utilize other valuation techniques, including the discounted cash flow method.

CLO Investments and CLO Loans Payable – The Company measures the financial liabilities of its consolidated CLOs

based on the fair value of the financial assets of its consolidated CLOs, as the Company believes the fair value of the

financial assets are more observable. The fair values of the CLO loan and bond assets are primarily based on

quotations from reputable dealers or relevant pricing services. In situations where valuation quotations are unavailable,

the assets are valued based on similar securities, market index changes, and other factors. The Company performs

certain procedures to ensure the reliability of the quotations from pricing services for its CLO assets and CLO

structured asset positions, which generally includes corroborating prices with a discounted cash flow analysis.

Generally, the loan and bond assets of the CLOs are not publicly traded and are classified as Level III. The fair values

of the CLO structured asset positions are determined based on both discounted cash flow analyses and third party

quotes. Those analyses consider the position size, liquidity, current financial condition of the CLOs, the third party

financing environment, reinvestment rates, recovery lags, discount rates and default forecasts and are compared to

broker quotations from market makers and third party dealers.

The Company measures the CLO loan payables held by third party beneficial interest holders on the basis of the fair

value of the financial assets of the CLO and the beneficial interests held by the Company. The Company continues to

measure the CLO loans payable that it holds at fair value based on relevant pricing services or discounted cash flow

analyses, as described above.

Fund Investments– The Company’s primary and secondary investments in external funds are generally valued as its

proportionate share of the most recent net asset value provided by the third-party general partners of the underlying

fund partnerships, adjusted for subsequent cash flows received from or distributed to the underlying fund partnerships.

The Company also adjusts for any changes in the market prices of public securities held by the underlying fund

partnerships and may also apply a market adjustment to reflect the estimated change in the fair value of the underlying

fund partnerships’ non-public investments from the date of the most recent net asset value provided by the third-party

general partners.

Investment professionals with responsibility for the underlying investments are responsible for preparing the investment

valuations pursuant to the policies, methodologies and templates prepared by the Company’s valuation group, which is a team

made up of dedicated valuation professionals reporting to the Company’s chief accounting officer. The valuation group is

responsible for maintaining the Company’s valuation policy and related guidance, templates and systems that are designed to be

consistent with the guidance found in ASC 820. These valuations, inputs and preliminary conclusions are reviewed by the fund

management teams. The valuations are then reviewed and approved by the respective fund valuation subcommittees, which

include the respective fund head(s), segment head, chief financial officer and chief accounting officer, as well as members of

the valuation group. The valuation group compiles the aggregate results and significant matters and presents them for review

and approval by the global valuation committee, which includes the Company’s Chief Executive Officer, Chief Risk Officer,

Chief Financial Officer, Chief Accounting Officer, and the business segment heads, and observed by the Chief Compliance

Officer, the Chief Audit Executive, the Company’s Audit Committee and others. Additionally, each quarter a sample of

valuations are reviewed by external valuation firms. Valuations of the funds’ investments are used in the calculation of accrued

performance allocations, or “carried interest.”

Investments, at Fair Value

Investments include (i) the Company’s ownership interests (typically general partner interests) in the Funds, including the

Company’s investment in Fortitude held through Carlyle FRL (which are accounted for as equity method investments), (ii) the

Company’s investment in NGP (which is accounted for as an equity method investment), (iii) the investments held by the

Consolidated Funds (which are presented at fair value in the Company’s condensed consolidated financial statements), and (iv)

certain credit-oriented investments, including investments in the CLOs and thecommon shares of Carlyle Secured Lending,

Inc. (“CGBD,” see Note 4, Investments, and Note 9, Related Party Transactions, for more information) which are accounted for

as trading securities.

Upon the sale of a security or other investment, the realized net gain or loss is computed on a weighted average cost

basis, with the exception of the investments held by the CLOs, which compute the realized net gain or loss on a first in, first out

basis. Securities transactions are recorded on a trade date basis.

Equity Method Investments

The Company accounts for all investments in which it has or is otherwise presumed to have significant influence,

including investments in the unconsolidated Funds and the Company’s investment in NGP, using the equity method of

accounting. The carrying value of equity method investments is determined based on amounts invested by the Company,

adjusted for the equity in earnings or losses of the investee (including performance allocations) allocated based on the

respective partnership agreement, less distributions received. The Company evaluates its equity method investments for

impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may not be

recoverable.

Cash and Cash Equivalents

Cash and cash equivalents include cash held at banks and cash held for distributions, including investments with original

maturities of less than three months when purchased. The Company is subject to credit risk should a financial institution be

unable to fulfil its obligations and if balances held at a financial institution exceed insured limits.

Cash and Cash Equivalents Held at Consolidated Funds

Cash and cash equivalents held at Consolidated Funds consists of cash and cash equivalents held by the Consolidated

Funds, which, although not legally restricted, is not available to fund the general liquidity needs of the Company.

Restricted Cash

Restricted cash primarily represents cash held by the Company’s foreign subsidiaries due to certain government

regulatory capital requirements as well as certain amounts held on behalf of Carlyle funds.

Corporate Treasury Investments

Corporate treasury investments represent investments in U.S. Treasury and government agency obligations, commercial

paper, certificates of deposit, other investment grade securities and other investments with original maturities of greater than

three months when purchased. These investments are accounted for as trading securities in which changes in the fair value of

each investment are recorded through investment income (loss). Any interest earned on debt investments is recorded through

interest and other income.

Derivative Instruments

The Company uses derivative instruments primarily to reduce its exposure to changes in foreign currency exchange rates.

Derivative instruments are recognized at fair value in the condensed consolidated balance sheets with changes in fair value

recognized in the condensed consolidated statements of operations for all derivatives not designated as hedging instruments.

Securities Sold Under Agreements to Repurchase

As it relates to certain European CLOs sponsored by the Company, securities sold under agreements to repurchase

(“Repurchase Agreements”) are accounted for as collateralized financing transactions. The Company provides securities to

counterparties to collateralize amounts borrowed under Repurchase Agreements on terms that permit the counterparties to

repledge or resell the securities to others. As of March 31, 2025,$265.9 million of securities were transferred to counterparties

under Repurchase Agreements and are included within investments in the condensed consolidated balance sheets. Cash

received under Repurchase Agreements is recognized as a liability within debt obligations in the condensed consolidated

balance sheets. See Note 6, Borrowings, for additional information.

Fixed Assets

Fixed assets consist of furniture, fixtures and equipment, leasehold improvements, computer hardware and software, and

fractional shares in corporate aircraft, and are stated at cost, less accumulated depreciation and amortization. Depreciation is

recognized on a straight-line method over the assets’ estimated useful lives, which for leasehold improvements are the lesser of

the lease terms or the life of the asset, andthree toseven years for other fixed assets. Fixed assets are reviewed for impairment

whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

Leases

The Company accounts for its leases in accordance with ASC 842, Leases, and recognizes a lease liability and right-of-

use (“ROU”) asset in the condensed consolidated balance sheets for contracts that it determines are leases or contain a lease.

The Company’s leases primarily consist of operating leases for office space in various countries around the world. The

Company also has operating leases for office equipment and vehicles, which are not significant. The Company does not

separate non-lease components from lease components for its office space and equipment operating leases and instead accounts

for each separate lease component and its associated non-lease component as a single lease component. ROU assets represent

the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to

make lease payments arising from the leases. The Company’s ROU assets and lease liabilities are recognized at lease

commencement based on the present value of lease payments over the lease term. Lease ROU assets include initial direct costs

incurred by the Company and are presented net of deferred rent and lease incentives. Absent an implicit interest rate in the

lease, the Company uses its incremental borrowing rate, adjusted for the effects of collateralization, based on the information

available at commencement in determining the present value of lease payments. The Company’s lease terms may include

options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options. Lease

expense for lease payments is recognized on a straight-line basis over the lease term. Lease ROU assets are reviewed for

impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.

The Company does not recognize a lease liability or ROU asset on the balance sheet for short-term leases. Instead, the

Company recognizes short-term lease payments as an expense on a straight-line basis over the lease term. A short-term lease is

defined as a lease that, at the commencement date, has a lease term of 12 months or less and does not include an option to

purchase the underlying asset that the lessee is reasonably certain to exercise. When determining whether a lease qualifies as a

short-term lease, the Company evaluates the lease term and the purchase option in the same manner as all other leases.

ROU assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount

of an asset may not be recoverable.

Intangible Assets and Goodwill

The Company’s intangible assets consist of acquired contractual rights to earn future fee income, including management

and advisory fees, customer relationships, and acquired trademarks. Finite-lived intangible assets are amortized over their

estimated useful lives, which range from four toeight years, and are reviewed for impairment whenever events or changes in

circumstances indicate that the carrying amount of the asset may not be recoverable.

Goodwill represents the excess of cost over the identifiable net assets of businesses acquired and is recorded in the

functional currency of the acquired entity. Goodwill is recognized as an asset and is reviewed for impairment annually as of

October 1 and between annual tests when events and circumstances indicate that impairment may have occurred.

Deferred Revenue

Deferred revenue represents management fees and other revenue received prior to the balance sheet date, which has not

yet been earned. Deferred revenue also includes transaction and portfolio advisory fees received by the Company that are

required to offset fund management fees pursuant to the related fund agreements.

Accumulated Other Comprehensive Income (Loss)

The Company’s accumulated other comprehensive income (loss) comprise foreign currency translation adjustments and

gains and losses on defined benefit plans sponsored by AlpInvest. The components of accumulated other comprehensive

income (loss) as of March 31, 2025 and December 31, 2024 were as follows:

As of
March 31, 2025December 31, 2024
(Dollars in millions)
Currency translation adjustments$(285.6)$(327.9)
Unrealized losses on defined benefit plans(3.1)(1.9)
Total$(288.7)$(329.8)

Foreign Currency Translation

Non-U.S. dollar denominated assets and liabilities are translated at period-end rates of exchange, and the condensed

consolidated statements of operations are translated at rates of exchange in effect throughout the period. Foreign currency gains

(losses) resulting from transactions outside of the functional currency of an entity of$(4.3) million and$0.5 million for the

three months ended March 31, 2025 and 2024, respectively, are included in general, administrative and other expenses in the

condensed consolidated statements of operations.

Recent Accounting Pronouncements

The Company considers the applicability and impact of all accounting standard updates (“ASU”) issued by the Financial

Accounting Standards Board (“FASB”). ASUs not listed below were assessed and either determined to be not applicableor

expected to have minimal impact on the Company’s condensed consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosure, which requires disclosure

of disaggregated information about a reporting entity’s effective tax rate reconciliation, using both percentages and reporting

currency amounts for specific standardized categories, as well as disclosure of income taxes paid disaggregated by jurisdiction.

The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company

does not expect the adoption of this guidance to have a material impact on the Company’s condensed consolidated financial

statements.

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires

disaggregated disclosures of certain categories of expenses on an annual and interim basis including employee compensation,

depreciation, and intangible asset amortization for each income statement line item that contains those expenses. The guidance

is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. The

Company is currently evaluating the impact of adopting this guidance on its condensed consolidated financial statements.

  1. Fair Value Measurement

The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the

fair value hierarchy levels as disclosed in Note 2, Summary of Significant Accounting Policies, as of March 31, 2025:

(Dollars in millions)Level ILevel IILevel IIITotal
Assets
Investments of Consolidated Funds(1):
Equity securities(2)$—$—$821.7$821.7
Bonds——495.8495.8
Loans——7,632.67,632.6
——8,950.18,950.1
Investments in CLOs and other:
Investments in CLOs——365.5365.5
Other investments(3)83.221.263.7168.1
83.221.2429.2533.6
Foreign currency forward contracts—2.5—2.5
Subtotal$83.2$23.7$9,379.3$9,486.2
Investments measured at net asset value387.0
Total$9,873.2
Liabilities
Loans payable of Consolidated Funds(4)(5)$—$—$7,680.3$7,680.3
Foreign currency forward contracts—3.0—3.0
Total$—$3.0$7,680.3$7,683.3

(1)This balance excludes$379.2 million of Investments of Consolidated Funds that are included in Investments measured at net asset

value, which relate to certain consolidated investment fund of funds in the Company’s Carlyle AlpInvest segment.

(2)This balance includes$684.8 million related to investments that have been bridged by the Company to investment funds and are

accounted for as consolidated VIEs as of March 31, 2025.

(3)The Level III balance excludes$55.6 million related to three corporate investments in equity securities which the Company has

elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to

ASC 321, Investments–Equity Securities. As a non-recurring fair value measurement, the fair value of these equity securities is

excluded from the tabular Level III rollforward disclosures.

(4)Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial

assets, less (i) the fair value of any beneficial interest held by the Company and (ii) the carrying value of any beneficial interests that

represent compensation for services.

(5)Loans payable of Consolidated Funds balance excludes a$121.4 million revolving credit balance.

The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the

above fair value hierarchy levels as of December 31, 2024:

(Dollars in millions)Level ILevel IILevel IIITotal
Assets
Investments of Consolidated Funds(1):
Equity securities(2)$—$—$572.0$572.0
Bonds——465.1465.1
Loans——6,431.46,431.4
Other—1.3—1.3
—1.37,468.57,469.8
Investments in CLOs and other:
Investments in CLOs——378.9378.9
Other investments(3)40.421.585.1147.0
40.421.5464.0525.9
Subtotal$40.4$22.8$7,932.5$7,995.7
Investments measured at net asset value320.7
Total$8,316.4
Liabilities
Loans payable of Consolidated Funds(4)(5)$—$—$6,809.1$6,809.1
Foreign currency forward contracts—0.6—0.6
Total$—$0.6$6,809.1$6,809.7

(1)This balance excludes$312.6 million of Investments of Consolidated Funds that are included in Investments measured at net asset

value, which relate to certain consolidated investment fund of funds in the Company’s Carlyle AlpInvest segment.

(2)This balance includes$441.9 million related to investments that have been bridged by the Company to investment funds and are

accounted for as consolidated VIEs as of December 31, 2024.

(3)The Level III balance excludes$55.4 million related to three corporate investments in equity securities which the Company has

elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to

ASC 321, Investments–Equity Securities. As a non-recurring fair value measurement, the fair value of these equity securities is

excluded from the tabular Level III rollforward disclosures.

(4)Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial

assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that

represent compensation for services.

(5)Loans payable of Consolidated Funds balance excludes a$55.1 million revolving credit balance.

The changes in financial instruments measured at fair value for which the Company has used Level III inputs to

determine fair value are as follows (Dollars in millions):

Financial Assets
Three Months Ended March 31, 2025
Investments of Consolidated Funds
EquitysecuritiesBondsLoansInvestments in CLOsOther investmentsTotal
Balance, beginning of period$572.0$465.1$6,431.4$378.9$85.1$7,932.5
Initial consolidation of funds(1)—24.0167.91.0—192.9
Transfer out related to the Exchange(2)————(50.4)(50.4)
Purchases253.256.42,225.31.137.82,573.8
Sales and distributions(9.0)(72.6)(943.9)(36.2)(11.2)(1,072.9)
Settlements——(358.9)——(358.9)
Realized and unrealized gains (losses), net
Included in earnings5.54.5(10.9)12.02.413.5
Included in other comprehensive income—18.4121.78.7—148.8
Balance, end of period$821.7$495.8$7,632.6$365.5$63.7$9,379.3
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date$4.8$4.2$0.6$10.2$5.1$24.9
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date$—$15.5$109.4$9.7$—$134.6
Financial Assets
Three Months Ended March 31, 2024
Investments of Consolidated Funds
EquitysecuritiesBondsLoansInvestments in CLOsOther investmentsTotal
Balance, beginning of period$377.6$522.5$5,862.1$532.6$84.6$7,379.4
Purchases24.846.41,397.41.0—1,469.6
Sales and distributions(6.1)(72.8)(729.5)(24.0)(0.9)(833.3)
Settlements——(464.7)——(464.7)
Realized and unrealized gains (losses), net
Included in earnings(9.0)15.672.815.29.5104.1
Included in other comprehensive income—(11.3)(73.2)(4.0)—(88.5)
Balance, end of period$387.3$500.4$6,064.9$520.8$93.2$7,566.6
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date$(9.0)$16.4$60.8$15.2$8.6$92.0
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date$—$(10.2)$(68.9)$(4.0)$—$(83.1)

(1)As a result of the initial consolidation ofone fund during the three months ended March 31, 2025.

(2)Represents the exchange of the BDC Preferred Shares, which were valued using Level III inputs, for common shares of CGBD, which

are valued using Level I inputs. See Note 9, Related Party Transactions, for more information.

Financial Liabilities
Loans Payable of Consolidated Funds
Three Months Ended March 31,
20252024
Balance, beginning of period$6,809.1$6,298.6
Initial consolidation of funds(1)193.8—
Borrowings782.1546.7
Paydowns(242.1)(207.7)
Sales(6.5)(288.7)
Realized and unrealized (gains) losses, net
Included in earnings1.289.4
Included in other comprehensive income142.7(86.0)
Balance, end of period$7,680.3$6,352.3
Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date$10.0$91.1
Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date$133.5$(87.9)

(1) As a result of the initial consolidation ofone fund during the three months ended March 31, 2025.

Realized and unrealized gains and losses included in earnings for Level III investments for investments in CLOs and

other investments are included in investment income (loss), and such gains and losses for investments of Consolidated Funds

and loans payable of the Consolidated Funds are included in net investment gains (losses) of Consolidated Funds in the

condensed consolidated statements of operations.

Gains and losses included in other comprehensive income for all Level III financial asset and liabilities are included in

accumulated other comprehensive loss and non-controlling interests in consolidated entities.

The following table summarizes quantitative information about the Company’s Level III inputs as of March 31, 2025:

Fair Value atValuation Technique(s)Unobservable Input(s)Range(Weighted Average)Impact to Valuation from Increase in Input
(Dollars in millions)March 31, 2025
Assets
Investments of Consolidated Funds:
Equity securities$4.6Consensus PricingIndicative Quotes ($ per share)0.00 - 79.83 (0.27)Higher
642.4Discounted Cash FlowDiscount Rates9% - 17% (11%)Lower
Terminal Growth Rate0% - 7% (4%)Higher
Comparable Multiple · EBITDA Multiple · 6.8x - 21.8x (12.3x) · Higher
TCF Multiple · 28.9x - 28.9x (28.9x) · Higher
71.7Discounted Cash FlowDiscount Rates7% - 34% (21%)Lower
Constant Prepayment Rate6% - 18% (9%)Lower
Constant Default Rate0% - 6% (2%)Lower
Recovery Rate0% - 40% (24%)Higher
103.0Other(1)N/AN/AN/A
Bonds495.8Consensus PricingIndicative Quotes (% of Par)31 - 107 (95)Higher
Loans7,527.4Consensus PricingIndicative Quotes (% of Par)0 - 103 (98)Higher
97.4Discounted Cash FlowDiscount Rates7% - 17% (10%)Lower
6.5Discounted Cash FlowDiscount Rates15% - 15% (15%)Lower
Constant Prepayment Rate8% - 14% (11%)Lower
Constant Default Rate1% - 1% (1%)Lower
Recovery Rate0% - 0% (0%)Higher
1.3Other(1)N/AN/AN/A
Investments in CLOs:
Senior secured notes305.7Consensus Pricing with Discounted Cash FlowIndicative Quotes (% of Par)87 - 101 (100)Higher
Discount Margins (Basis Points)86 - 1,355 (193)Lower
Default Rates2% - 2% (2%)Lower
Recovery Rates60% - 60% (60%)Higher
Subordinated notes and preferred shares59.8Consensus Pricing with Discounted Cash FlowIndicative Quotes (% of Par)1 - 100 (42)Higher
Discount Rates5% - 36% (15%)Lower
Default Rates2% - 2% (2%)Lower
Recovery Rates60% - 60% (60%)Higher
Other investments:
Aviation subordinated notes8.5Discounted Cash FlowDiscount Rates21% - 21% (21%)Lower
Loans55.2Consensus Pricing with Discounted Cash FlowIndicative Quotes (% of Par)97 - 99 (98)Higher
Discount Rates9% - 16% (11%)Lower
Comparable Multiple · EBITDA Multiple · 6.0x - 6.0x (6.0x) · Higher
Total$9,379.3
Liabilities
Loans payable of Consolidated Funds:
Senior secured notes$7,434.2Other(2)N/AN/AN/A
Subordinated notes and preferred shares246.1Consensus Pricing with Discounted Cash FlowIndicative Quotes (% of Par)15 - 89 (53)Higher
Discount Rates(3)% - 35% (13%)Lower
Default Rates1% - 2% (2%)Lower
Recovery Rates60% - 60% (60%)Higher
Total$7,680.3

(1)Fair value approximates transaction price that was in close proximity to the reporting date.

(2)Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets,

less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent

compensation for services.

The following table summarizes quantitative information about the Company’s Level III inputs as of December 31, 2024:

Fair Value atValuation Technique(s)Unobservable Input(s)Range(Weighted Average)Impact to Valuation from Increase in Input
(Dollars in millions)December 31, 2024
Assets
Investments of Consolidated Funds:
Equity securities$3.9Consensus PricingIndicative Quotes ($ per share)0.00 - 112.17 (0.01)Higher
485.0Discounted Cash FlowDiscount Rates10% - 13% (11%)Lower
Terminal Growth Rate3% - 7% (6%)Higher
Comparable Multiple · EBITDA Multiple · 7.7x - 23.2x (12.8x) · Higher
TCF Multiple · 26.0x - 26.0x (26.0x) · Higher
38.2Discounted Cash FlowDiscount Rates14% - 34% (18%)Lower
Constant Prepayment Rate6% - 16% (11%)Lower
Constant Default Rate1% - 4% (2%)Lower
Recovery Rate0% - 40% (17%)Higher
44.9Other(1)N/AN/AN/A
Bonds465.1Consensus PricingIndicative Quotes (% of Par)30 - 103 (93)Higher
Loans6,408.2Consensus PricingIndicative Quotes (% of Par)0 - 105 (97)Higher
10.2Discounted Cash FlowDiscount Rates9% - 19% (18%)Lower
6.4Discounted Cash FlowDiscount Rates16% - 16% (16%)Lower
Constant Prepayment Rate8% - 14% (11%)Lower
Constant Default Rate1% - 1% (1%)Lower
Recovery Rate0% - 0% (0%)Higher
Other6.6Other(1)N/AN/AN/A
Investments in CLOs
Senior secured notes321.8Discounted Cash Flow with Consensus PricingIndicative Quotes (% of Par)80 - 101 (99)Higher
Discount Margins (Basis Points)113 - 1,535 (214)Lower
Default Rates2% - 2% (2%)Lower
Recovery Rates60% - 60% (60%)Higher
Subordinated notes and preferred shares57.1Discounted Cash Flow with Consensus PricingIndicative Quotes (% of Par)1 - 103 (38)Higher
Discount Rate4% - 35% (16%)Lower
Default Rates1% - 2% (2%)Lower
Recovery Rates60% - 60% (60%)Higher
Other investments:
BDC preferred shares53.4Other(2)Net Asset Value per Share16.80 - 16.80 (16.80)Lower
Aviation subordinated notes2.9Discounted Cash FlowDiscount Rates21% - 21% (21%)Lower
Loans28.8Consensus PricingIndicative Quotes (% of Par)99 - 99 (99)Higher
Total$7,932.5
Liabilities
Loans payable of Consolidated Funds:
Senior secured notes$6,598.8Other(3)N/AN/AN/A
Subordinated notes and preferred shares210.3Discounted Cash Flow with Consensus PricingIndicative Quotes (% of Par)11 - 87 (34)Higher
Discount Rates2% - 35% (15%)Lower
Default Rates1% - 2% (2%)Lower
Recovery Rates60% - 60% (60%)Higher
Total$6,809.1

(1)Fair value approximates transaction price that was in close proximity to the reporting date.

(2)See Note 9, Related Party Transactions, for more information.

(3)Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets,

less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent

compensation for services.

  1. Investments

Investments consist of the following:

As of
March 31, 2025December 31, 2024
(Dollars in millions)
Accrued performance allocations$6,985.8$7,053.5
Principal equity method investments, excluding performance allocations3,153.23,292.3
Principal investments in CLOs365.5378.9
Other investments235.4212.0
Total$10,739.9$10,936.7

Accrued Performance Allocations

The components of accrued performance allocations are as follows:

As of
March 31, 2025December 31, 2024
(Dollars in millions)
Global Private Equity$4,723.5$4,910.2
Global Credit589.8527.1
Carlyle AlpInvest1,672.51,616.2
Total$6,985.8$7,053.5

Approximately 23% and 20% of accrued performance allocations at March 31, 2025 and December 31, 2024,

respectively, was related to Carlyle Partners VII, L.P., one of the Company’s Global Private Equity funds.

Accrued performance allocations are shown gross of the Company’s accrued performance allocations and incentive fee

related compensation (see Note 7, Accrued Compensation and Benefits), and accrued giveback obligations, which are

separately presented in the condensed consolidated balance sheets. The components of the accrued giveback obligations are as

follows:

As of
March 31, 2025December 31, 2024
(Dollars in millions)
Global Private Equity$(19.1)$(18.5)
Global Credit(25.5)(25.5)
Total$(44.6)$(44.0)

Principal Equity-Method Investments, Excluding Performance Allocations

The Company’s principal equity method investments (excluding performance allocations) include its fund investments in

Global Private Equity, Global Credit, and Carlyle AlpInvest typically as general partner interests, and its investments in

Fortitude through a Carlyle-affiliated fund (included within Global Credit) and NGP (included within Global Private Equity),

which are not consolidated. Principal investments are related to the following segments:

As of
March 31, 2025December 31, 2024
(Dollars in millions)
Global Private Equity(1)$1,660.0$1,818.0
Global Credit(2)1,188.41,157.0
Carlyle AlpInvest304.8317.3
Total$3,153.2$3,292.3

(1)The balance includes$766.3 million and$912.0 million as of March 31, 2025 and December 31, 2024, respectively, related to the

Company’s equity method investments in NGP.

(2)The balance includes$737.4 million and$723.5 million as of March 31, 2025 and December 31, 2024, respectively, related to the

Company’s investment in Fortitude.

Investment in Fortitude

In November 2018, the Company acquired a 19.9% interest in Fortitude Group Holdings, LLC (“Fortitude Holdings”), a

wholly owned subsidiary of American International Group, Inc. (“AIG”). Fortitude Holdings owns 100% of the outstanding

common shares of Fortitude Reinsurance Company Ltd., a Bermuda domiciled reinsurer (“Fortitude Re”). The Company paid

$381 million in cash at closing and paid$95 million in additional deferred consideration in 2024. In May 2020, the initial

purchase price was adjusted upward by$99.5 million in accordance with the purchase agreement as Fortitude Holdings chose

not to distribute a planned non-pro rata dividend to AIG, of which the Company paid$79.6 million in May 2020. The

remaining$19.9 million was paid in 2024.

In June 2020, Carlyle FRL, L.P. (“Carlyle FRL”), a Carlyle-affiliated investment fund, and T&D United Capital Co., Ltd.

(“T&D”), a strategic third-party investor, acquired a 51.6% ownership interest and 25.0% ownership interest, respectively, in

Fortitude Holdings from AIG. At closing, the Company contributed its existing 19.9% interest in Fortitude Holdings to Carlyle

FRL, such that Carlyle FRL held a 71.5% interest in Fortitude Holdings. Taken together, Carlyle FRL and T&D had 96.5%

ownership of Fortitude Holdings. In October 2021, Carlyle FRL, T&D and an affiliate of AIG contributed the entirety of their

interest in Fortitude Holdings to FGH Parent, L.P. (“FGH Parent”), a newly-formed entity interposed as the direct parent of

Fortitude Holdings, in exchange for an equivalent ownership interest in FGH Parent. References to “Fortitude” prior to this

restructuring refer to Fortitude Holdings and refer to FGH Parent for subsequent periods.

In March 2022, the Company raised$2.0 billion in third-party equity capital from certain investors in Carlyle FRL and

T&D, and committed$100 million from the Company for additional equity capital in Fortitude. Upon Fortitude calling the

remaining commitments from the capital raise in May 2023, the Company’s indirect ownership of Fortitude decreased to

10.5%. Effective October 2023, a third-party investor in Carlyle FRL received a distribution in kind of its interest in FGH

Parent held indirectly through the fund, reducing Carlyle FRL’s ownership in FGH Parent to 38.5%. Following the additional

capital contributions in 2022 and 2023, Carlyle FRL and its strategic third-party investors collectively hold a 97.5% interest in

FGH Parent.

In November 2024, Fortitude declared and paid a$200.0 million dividend, of which Carlyle FRL’s share was

$76.9 million. The Company received a distribution from Carlyle FRL of$21.0 million related to this dividend, of which

$7.9 million was recognized as realized principal investment income, and the balance as return of capital. As of March 31,

2025, the carrying value of the Company’s investment in Carlyle FRL, which is an investment company that accounts for its

investment in Fortitude at fair value, was$737.4 million, relative to equity invested of$666.8 million.

The Company has an asset management relationship with Fortitude pursuant to which Fortitude committed to allocate

assets in asset management strategies and vehicles of the Company and its affiliates. As of March 31, 2025, Fortitude, its

affiliates and certain Fortitude reinsurance counterparties have committed approximately$20.6 billion of capital to-date to

various Carlyle strategies. On April 1, 2022, the Company entered into a strategic advisory services agreement with certain

subsidiaries of Fortitude through Carlyle Insurance Solutions Management L.L.C. (“CISM”), an investment adviser. Under the

agreement, CISM provides Fortitude with certain services, including business development and growth, transaction origination

and execution, and capital management services in exchange for a recurring management fee based on Fortitude’s general

account assets, which adjusts within an agreed range based on Fortitude’s overall profitability. Third-party investors who

participated in the March 2022 capital raise also made a minority investment in CISM, which is reflected as non-controlling

interest in consolidated entities in the condensed consolidated financial statements.

Investment in NGP

The Company has equity interests in NGP Management Company, L.L.C. (“NGP Management”), the general partners of

certain carry funds advised by NGP, and principal investments in certain NGP funds as described below. These investments are

included in the Global Private Equity segment. NGP Management serves as the investment advisor to the NGP Energy Funds.

The Company does not control NGP and accounts for its investments in NGP under the equity method of accounting.

The Company’s investments in NGP as of March 31, 2025 and December 31, 2024 are as follows:

As of
March 31, 2025December 31, 2024
(Dollars in millions)
Investment in NGP Management$275.7$369.2
Investments in NGP general partners - accrued performance allocations441.4489.4
Principal investments in NGP funds49.253.4
Total investments in NGP$766.3$912.0

NGP Restructuring. On March 31, 2025, the Company restructured the terms of its strategic investment in NGP (the

“Restructuring”) to further align the interests of the Company and NGP. The Restructuring eliminated previous restrictions on

the Company’s ability to pursue domestic energy strategies, established a new capital markets fees arrangement with NGP, and

terminated the Company’s obligation to grant up to$10 million of its common shares to NGP annually following a final grant

made with respect to 2030. Additionally, in order to facilitate the development of future funds while substantially maintaining

the Company’s economics on existing funds, the Restructuring reduced the Company’s allocation of the management fee

related revenues of NGP Management related to future funds, as well as its share of the performance allocations received by

current and future NGP fund general partners, as discussed further below.

Prior to the Restructuring, the Company’s equity interests in NGP Management entitled the Company to an allocation of

income equal to 55.0% of the management fee related revenues earned by NGP Management. Subsequent to the Restructuring,

for all funds that held an initial closing after December 31, 2024, the Company’s allocations of income for the management fee

related revenues willbe based on a sliding scale of the total annual management fee related revenues accrued from all such

funds in the aggregate up to 55.0%, including all management fees being retained by NGP for the years 2025 through 2028 on

such future NGP funds. The Company identified the reduction of its allocation of the management fee related revenues of NGP

Management as an indicator of impairment and performed an impairment analysis. As a result of the Restructuring, the

Company concluded that the carrying value of its investment in NGP Management was impaired and recorded an impairment

charge of$92.5 million during the three months ended March 31, 2025, representing the difference in the carrying value of the

investment of$352.5 million and its fair value of$260.0 million at the time of Restructuring. The Company utilized a

discounted cash flow method for determining the fair value of its equity method investment, which is a Level III valuation

within the fair value hierarchy and utilizes significant unobservable assumptions, including discount rates and long-term growth

rates. The allocation of management fee related revenues for existing NGP funds remains unchanged, including the Company’s

interest in management fees from NGP XI, NGP XII, and NGP XIII.

The impairment charge created new basis differences with an estimated fair value of$165 million within the equity

method investment. These basis differences will be amortized over an estimated useful life ranging from five toseven years as a

reduction of principal investment income.

The Company’s investment in the general partners of the NGP Carry Funds entitled it to 47.5% (38.0% to 42.75% in the

case of certain funds) of the performance allocations received by certain current and future NGP fund general partners prior to

the Restructuring. In connection with the Restructuring, the Company’s allocation of the performance allocations from existing

NGP Carry Funds was reduced to a range of 35.1% to 43.8%, which resulted in a$38 million reduction in accrued performance

allocations during the three months ended March 31, 2025. The Company’s interest in the performance allocations from future

NGP Carry Funds will be based on a sliding scale of the fee paying capital raised in each future NGP Carry Fund, up to 47.5%

of the performance allocations received by future NGP Carry Funds.

The impairment charge related to the investment in NGP Management and the reduction in accrued performance

allocations from NGP Carry Funds are recorded in Principal investment income (loss) in the condensed consolidated statements

of operations and excluded from Distributable Earnings, as defined in Note 15, Segment Reporting.

Investment in NGP Management. As referenced above, the Company’s equity interests in NGP Management entitle the

Company to an allocation of income equal to 55.0% of the management fee related revenues earned by existing funds, and up to

55.0% of management fees earned on future NGP funds in the aggregate, including all management fees being retained by NGP

for the years 2025 through 2028 on such future NGP funds. The Company records investment income (loss) for its equity

income allocation from NGP management fee related revenues and also records its share of any allocated expenses from NGP

Management, as well as expenses associated with the compensatory elements of the investment and any impairment charges.

The net investment income (loss) recognized in the Company’s condensed consolidated statements of operations for thethree

months ended March 31, 2025 and 2024 were as follows:

Three Months Ended March 31,
20252024
(Dollars in millions)
Management fee related revenues from NGP Management$16.1$17.3
Expenses related to the investment in NGP Management(3.6)(3.2)
Impairment of investment in NGP Management(92.5)—
Net investment income from NGP Management$(80.0)$14.1

Management fee related revenues from NGP Management were primarily driven by NGP XI, NGP XII, and NGP XIII

during thethree months ended March 31, 2025 and NGP XII and NGP XI during thethree months ended March 31, 2024.

These funds calculate management fees as 1.5% of the limited partners’ commitments less any return of capital or write-offs

during the investment period. Following the investment period, the basis on which fund management fees are generally

calculated is further reduced by a reserve for future management fees and operating costs.

Investment in the General Partners of NGP Carry Funds. As referenced above, the Company’s investment in the general

partners of the NGP Carry Funds entitle it toup to 47.5% of the performance allocations received by NGP fund general

partners. The Company records its equity income allocation from NGP performance allocations in principal investment income

(loss) from equity method investments rather than performance allocations in its condensed consolidated statements of

operations. The Company recognized net investment earnings (losses) related to these performance allocations (including the

$38.0 million reduction related to the Restructuring) of$(28.5) million and$15.3 million for thethree months ended March 31,

2025 and 2024, respectively, in its condensed consolidated statements of operations.

Principal Investments in NGP Funds. The Company also holds principal investments in the NGP Carry Funds. The

Company recognized net investment earnings (losses) related to principal investment income (loss) in its condensed

consolidated statements of operations of$1.3 million and$2.0 million for thethree months ended March 31, 2025 and 2024,

respectively.

Principal Investments in CLOs and Other Investments

Principal investments in CLOs as of March 31, 2025 and December 31, 2024 were$365.5 million and$378.9 million,

respectively, and consisted of investments in CLO senior and subordinated notes. A portion of the Company’s principal

investments in CLOs is collateral to CLO term loans (see Note 6, Borrowings). As of March 31, 2025 other investments include

the Company’s investment in common shares of CGBD at fair value of$48.6 million. As of December 31, 2024, other

investments include the Company’s investment in preferred shares of CGBD (the “BDC Preferred Shares”) at fair value of

$53.4 million, which were exchanged for common shares effective March 27, 2025 (see Note 9, Related Party Transactions).

Investment Income (Loss)

The components of investment income (loss) are as follows:

Three Months Ended March 31,
20252024
(Dollars in millions)
Performance allocations
Realized$332.9$389.7
Unrealized(110.0)(546.7)
222.9(157.0)
Principal investment income (loss) from equity method investments (excluding performance allocations)
Realized(29.4)53.7
Unrealized(33.3)(6.6)
(62.7)47.1
Principal investment income (loss) from investments in CLOs and other investments
Realized(2.0)2.2
Unrealized1.623.8
(0.4)26.0
Total$159.8$(83.9)

The performance allocations included in revenues are derived from the following segments:

Three Months Ended March 31,
20252024
(Dollars in millions)
Global Private Equity$85.0$(363.5)
Global Credit79.065.1
Carlyle AlpInvest58.9141.4
Total$222.9$(157.0)

The following tables summarize the funds that are the primary drivers of performance allocations for thethree months

ended March 31, 2025 and 2024, as well as the total revenue recognized, including performance allocations as well as fund

management fees and principal investment income:

Three Months Ended March 31, 2025
(Dollars in millions)
Global Private EquityCarlyle Partners VII, L.P.$234.1
Global Private EquityCarlyle Asia Partners V, L.P.(227.8)
Three Months Ended March 31, 2024
(Dollars in millions)
Global Private EquityCarlyle Europe Partners V, L.P.$(171.5)
Global Private EquityCarlyle Partners VI, L.P.(86.7)
Global Private EquityCarlyle Partners VII, L.P.(73.1)

Carlyle’s income (loss) from its principal equity method investments consists of:

Three Months Ended March 31,
20252024
(Dollars in millions)
Global Private Equity$(95.6)$28.8
Global Credit19.211.4
Carlyle AlpInvest13.76.9
Total$(62.7)$47.1

Principal investment income for Global Private Equity for thethree months ended March 31, 2025 included the

impairment charge related to the investment in NGP Management of$92.5 million and the reduction in accrued performance

allocations from NGP Carry Funds of$38.0 million related to the Restructuring. Principal investment income for Global Private

Equity for thethree months ended March 31, 2024 included the Company’s equity income allocation from NGP performance

allocations of$15.3 million.

Investments of Consolidated Funds

The Company consolidates the financial positions and results of operations of certain CLOs in which it is the primary

beneficiary. During thethree months ended March 31, 2025, the Company became the primary beneficiary ofone additional

CLO. Investments in Consolidated Funds as of March 31, 2025 also included$684.8 million related to investments that have

been bridged by the Company to investment funds and are accounted for as consolidated VIEs.

There were no individual investments with a fair value greater than five percent of the Company’s total assets for any

period presented.

Interest and Other Income of Consolidated Funds

The components of interest and other income of Consolidated Funds are as follows:

Three Months EndedMarch 31,
20252024
(Dollars in millions)
Interest income from investments$123.0$142.6
Other income10.422.3
Total$133.4$164.9

Net Investment Income (Loss) of Consolidated Funds

Net investment income (loss) of Consolidated Funds includes net realized gains (losses) from sales of investments and

unrealized gains (losses) resulting from changes in fair value of the Consolidated Funds’ investments. The components of Net

investment income (loss) of Consolidated Funds are as follows:

Three Months EndedMarch 31,
20252024
(Dollars in millions)
Gains from investments of Consolidated Funds$7.0$82.7
Losses from liabilities of CLOs(0.9)(89.7)
Total$6.1$(7.0)

The following table presents realized and unrealized gains (losses) earned from investments of the Consolidated Funds:

Three Months EndedMarch 31,
20252024
(Dollars in millions)
Realized gains (losses)$(0.4)$(21.2)
Net change in unrealized gains7.4103.9
Total$7.0$82.7
  1. Intangible Assets and Goodwill

The following table summarizes the carrying amount of intangible assets as of March 31, 2025 and December 31, 2024:

As of
March 31, 2025December 31, 2024
(Dollars in millions)
Acquired contractual rights$925.0$922.7
Accumulated amortization(425.7)(392.2)
Finite-lived intangible assets, net499.3530.5
Goodwill103.9103.6
Intangible Assets, net$603.2$634.1

As discussed in Note 2, Summary of Significant Accounting Policies, the Company reviews its intangible assets for

impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable,

and considers factors including, but not limited to, expected cash flows from its interest in future management fees and the

ability to raise new funds. The Company recordedno impairment losses of intangible assets for the periods presented.

Intangible asset amortization expense was$32.6 million for both thethree months ended March 31, 2025 and 2024, and

is included in general, administrative, and other expenses in the condensed consolidated statements of operations. Certain

intangible assets are held by entities of which the functional currency is not the U.S. dollar. Any corresponding currency

translation is recorded in accumulated other comprehensive income (loss).

The following table summarizes the expected amortization expense for 2025 through 2029 and thereafter (Dollars in

millions):

Year ending December 31,
2025 (excluding the three months ended March 31, 2025)$98.6
2026131.3
2027121.1
2028114.0
202931.8
Thereafter2.5
$499.3
  1. Borrowings

The Company borrows and enters into credit agreements for its general operating and investment purposes. The

Company’s debt obligations consist of the following:

March 31, 2025December 31, 2024
BorrowingOutstandingCarryingValueBorrowingOutstandingCarryingValue
(Dollars in millions)
CLO Borrowings (See below)$309.1$300.4$289.4$288.0
3.500% Senior Notes Due 9/19/2029425.0423.0425.0422.9
5.625% Senior Notes Due 3/30/2043600.0600.5600.0600.5
5.650% Senior Notes Due 9/15/2048350.0346.6350.0346.6
4.625% Subordinated Notes Due 5/15/2061500.0485.6500.0485.5
Total debt obligations$2,184.1$2,156.1$2,164.4$2,143.5

Senior Credit Facility

As of March 31, 2025, the senior credit facility included$1.0 billion in a revolving credit facility. The Company’s

borrowing capacity is subject to the ability of the financial institutions in the banking syndicate to fulfill their respective

obligations under the revolving credit facility. The revolving credit facility is scheduled to mature on April 29, 2027, and

principal amounts outstanding under the revolving credit facility accrue interest, at the option of the borrowers, either (a) at an

alternate base rate plus an applicable margin not to exceed 0.50% per annum, or (b) at SOFR (or similar benchmark rate for

non-U.S. dollar borrowings) plus a 0.10% adjustment and an applicable margin not to exceed 1.50% per annum (at March 31,

2025, the interest rate was 5.42%). The Company madeno borrowings under the revolving credit facility during thethree

months ended March 31, 2025 and 2024, and there wasno amount outstanding as of March 31, 2025.

Global Credit Revolving Credit Facility

Certain subsidiaries of the Company are parties to a revolving line of credit, primarily intended to support certain lending

activities within the Global Credit segment. As currently amended, the Global Credit Revolving Credit Facility provides for a

revolving line of credit with a capacity of$300 million, which matures in September 2027, and a second revolving line of credit

with a capacity of$200 million, which matures in August 2025. The Company’s borrowing capacity is subject to the ability of

the financial institutions in the banking syndicate to fulfill their respective obligations under the Global Credit Revolving Credit

Facility. Principal amounts outstanding accrue interest at applicable SOFR or Eurocurrency rates plus an applicable margin of

2.00% or an alternate base rate plus an applicable margin of 1.00%. During thethree months ended March 31, 2025 and 2024,

the Company madeno borrowings under the Global Credit Revolving Credit Facility. As of March 31, 2025, there wasno

borrowing outstanding under the Global Credit Revolving Credit Facility.

CLO Borrowings

For certain of the Company’s CLOs, the Company finances a portion of its investment in the CLOs through the proceeds

received from term loans and other financing arrangements with financial institutions. The Company’s outstanding CLO

borrowings consist of the following (Dollars in millions):

Formation Date · Borrowing Outstanding March 31, 2025 · Borrowing Outstanding December 31, 2024 · Maturity Date (1) · Interest Rate as of March 31, 2025
February 28, 2017$21.7$23.5September 21, 20295.20%(2)
December 6, 201721.525.5January 15, 20316.11%(3)
March 15, 20191.81.7March 15, 203210.61%(4)
August 20, 20193.93.7August 15, 20327.29%(4)
September 15, 202019.218.4April 15, 20334.37%(4)
January 8, 202120.119.2January 15, 20345.28%(4)
March 30, 202116.916.5March 15, 20324.24%(4)
April 21, 20213.53.3April 15, 20338.63%(4)
May 21, 202110.211.6November 17, 20313.98%(4)
June 4, 202120.219.4January 16, 20345.06%(4)
June 10, 20211.31.2November 17, 20315.41%(4)
July 15, 202115.114.5July 15, 20345.08%(4)
July 20, 202120.219.3July 20, 20315.02%(4)
August 4, 202115.815.6August 15, 20324.31%(4)
October 27, 202123.522.5October 15, 20355.19%(4)
January 6, 202220.319.4February 15, 20354.94%(4)
February 22, 202220.319.5November 10, 20354.99%(4)
September 5, 2023—5.1August 28, 2031N/A(5)
April 25, 202418.017.2April 25, 20375.55%(4)
December 19, 202415.312.3January 15, 20395.39%(4)
March 10, 202520.3—April 15, 20284.88%(4)
$309.1$289.4

(1)Maturity date is earlier of date indicated or the date that the CLO is dissolved.

(2)Incurs interest at EURIBOR plus applicable margins as defined in the agreement.

(3)Incurs interest at SOFR plus 1.81%.

(4)Incurs interest at the average effective interest rate of each class of purchased securities plus 0.50% spread percentage.

(5)Term loan was fully repaid during thethree months ended March 31, 2025.

The CLO term loans are secured by the Company’s investments in the respective CLO, have a general unsecured interest

in the Carlyle entity that manages the CLO, and generally do not have recourse to any other Carlyle entity. Interest expense for

thethree months ended March 31, 2025 and 2024 was$3.8 million and$6.8 million, respectively. The fair value of the

outstanding balance of the CLO term loans at March 31, 2025 approximated par value based on current market rates for similar

debt instruments. These CLO term loans are classified as Level III within the fair value hierarchy.

European CLO Financing - February 28, 2017

A subsidiary of the Company is a party to a financing agreement with several financial institutions. As of March 31,

2025, the financing agreement provided the Company with a term loan of€20.0 million ($21.7 million at March 31, 2025). This

term loan is secured by the Company’s investments in the retained notes in certain European CLOs that were formed in 2014

and 2015. This term loan will mature on the earlier of September 21, 2029 or the date that the certain European CLO retained

notes have been redeemed. The Company may prepay the term loan in whole or in part at any time. Interest on this term loan

accrues at EURIBOR plus applicable margins (5.20% at March 31, 2025).

Master Credit Agreement - Term Loans

The Company assumed liabilities under master credit agreements previously entered into by CBAM under which a

financial institution provided term loans to CBAM for the purchase of eligible interests in CLOs. Term loans issued under these

master credit agreements are secured by the Company’s investment in the respective CLO as well as any senior management

fee and subordinated management fee payable by each CLO. Term loans generally bear interest at SOFR plus a weighted

average spread over SOFR on the CLO notes, which is due quarterly. As of March 31, 2025, term loans under these agreements

had$21.5 million outstanding. The master credit agreement matures in January 2031.

CLO Repurchase Agreements

On February 5, 2019, the Company entered into a master credit facility agreement (the “Carlyle CLO Financing Facility”)

to finance a portion of the risk retention investments in certain European CLOs managed by the Company. Each transaction

entered into under the Carlyle CLO Financing Facility will bear interest at a rate based on the weighted average effective

interest rate of each class of securities that have been sold plus a spread to be agreed upon by the parties. As of March 31, 2025,

€182.5 million ($197.3 million) was outstanding under the Carlyle CLO Financing Facility. Additional borrowings may be

made on terms agreed upon by the Company and the counterparty subject to the terms and conditions of the Carlyle CLO

Financing Facility.

Each transaction entered into under the CLO Financing Facility provides for payment netting and, in the case of a default

or similar event with respect to the counterparty to the CLO Financing Facility, provides for netting across transactions.

Generally, upon a counterparty default, the Company can terminate all transactions under the CLO Financing Facility and offset

amounts it owes in respect of any one transaction against collateral, if any, or other amounts it has received in respect of any

other transactions under the CLO Financing Facility; provided, however, that in the case of certain defaults, the Company may

only be able to terminate and offset solely with respect to the transaction affected by the default. During the term of a

transaction entered into under the CLO Financing Facility, the Company will deliver cash or additional securities acceptable to

the counterparty if the securities sold are in default. Upon termination of a transaction, the Company will repurchase the

previously sold securities from the counterparty at a previously determined repurchase price. The CLO Financing Facility may

be terminated at any time upon certain defaults or circumstances agreed upon by the parties.

The Repurchase Agreements may result in credit exposure in the event the counterparty to the transaction is unable to

fulfill its contractual obligations. The Company minimizes the credit risk associated with these activities by monitoring

counterparty credit exposure and collateral values. Other than margin requirements, the Company is not subject to additional

terms or contingencies which would expose the Company to additional obligations based upon the performance of the securities

pledged as collateral.

The Company assumed liabilities under a master credit facility agreement previously entered into by CBAM (the

“CBAM CLO Financing Facility,” together with the Carlyle CLO Financing Facility, the “CLO Financing Facilities”) to

finance a portion of the risk retention investments in certain European CLOs managed by CBAM. The maximum facility

amount is€100.0 million, but may be expanded on such terms agreed upon by the Company and the counterparty subject to the

terms and conditions of the CBAM CLO Financing Facility. Each transaction entered into under the CBAM CLO Financing

Facility will bear interest at a rate based on the weighted average effective interest rate of each class of securities that have been

sold plus a spread to be agreed upon by the parties. As of March 31, 2025,€63.4 million ($68.6 million) was outstanding under

the CBAM CLO Financing Facility.

Senior Notes

Certain indirect subsidiaries of the Company have issued long term borrowings in the form of senior notes, on which

interest is payable semi-annually in arrears. The following table provides information regarding these senior notes (Dollars in

millions):

Interest Expense
Fair Value (1)As of · Three Months EndedMarch 31,
Aggregate Principal AmountMarch 31, 2025December 31, 202420252024
3.500% Senior Notes Due 9/19/2029 (2)$425.0$404.3$401.2$3.8$3.8
5.625% Senior Notes Due 3/30/2043 (3)600.0587.9589.58.48.4
5.650% Senior Notes Due 9/15/2048 (4)350.0341.9338.15.05.0
$17.2$17.2

(1)Including accrued interest. Fair value is based on indicative quotes and the notes are classified as Level II within the fair

value hierarchy.

(2)Issued in September 2019 at 99.841% of par.

(3)Issued$400.0 million in aggregate principal at 99.583% of par in March 2013. An additional$200.0 million in aggregate

principal was issued at 104.315% of par in March 2014, and is treated as a single class with the outstanding$400.0 million

in senior notes previously issued.

(4)Issued in September 2018 at 99.914% of par.

The issuers may redeem the senior notes, in whole at any time or in part from time to time, at a price equal to the greater

of (i)100% of the principal amount of the notes being redeemed and (ii) the sum of the present values of the remaining

scheduled payments of principal and interest on any notes being redeemed discounted to the redemption date on a semiannual

basis at the Treasury Rate plus 40 basis points (30 basis points in the case of the 3.500% senior notes), plus in each case accrued

and unpaid interest on the principal amounts being redeemed.

Subordinated Notes

In May 2021, an indirect subsidiary of the Company issued$435.0 million aggregate principal amount of 4.625%

Subordinated Notes due May 15, 2061 (the “Subordinated Notes”), on which interest is payable quarterly accruing from May

11, 2021. In June 2021, an additional$65.0 million aggregate principal amount of these Subordinated Notes were issued and

are treated as a single series with the already outstanding$435.0 million aggregate principal amount. The Subordinated Notes

are unsecured and subordinated obligations of the issuer, and are fully and unconditionally guaranteed (the “Guarantees”),

jointly and severally, on a subordinated basis, by the Company, each of the Carlyle Holdings partnerships, and CG Subsidiary

Holdings L.L.C., an indirect subsidiary of the Company (collectively, the “Guarantors”). The Consolidated Funds are not

guarantors, and as such, the assets of the Consolidated Funds are not available to service the Subordinated Notes under the

Guarantee. The Subordinated Notes may be redeemed at the issuer’s option, in whole or in part, at any time and from time to

time on or after June 15, 2026, prior to their stated maturity, at a redemption price equal to their principal amount plus any

accrued and unpaid interest to, but excluding, the date of redemption. If interest due on the Subordinated Notes is deemed to no

longer be deductible in the U.S., a “Tax Redemption Event,” the Subordinated Notes may be redeemed, in whole, but not in

part, within 120 days of the occurrence of such event at a redemption price equal to their principal amount plus accrued and

unpaid interest to, but excluding, the date of redemption. In addition, the Subordinated Notes may be redeemed, in whole, but

not in part, at any time prior to May 15, 2026, within 90 days of the rating agencies determining that the Subordinated Notes

should no longer receive partial equity treatment pursuant to the rating agency’s criteria, a “rating agency event,” at a

redemption price equal to 102% of their principal amount plus any accrued and unpaid interest to, but excluding, the date of

redemption.

As of March 31, 2025 and December 31, 2024, the fair value of the Subordinated Notes was$348.0 million and

$356.4 million, respectively. Fair value is based on active market quotes and the notes are classified as Level I within the fair

value hierarchy. For thethree months ended March 31, 2025 and 2024, the Company incurred$5.9 million and$5.9 million,

respectively, of interest expense on the Subordinated Notes.

Debt Covenants

The Company is subject to various financial covenants under its loan agreements including, among other items,

maintenance of a minimum amount of management fee-earning assets. The Company is also subject to various non-financial

covenants under its loan agreements and the indentures governing its senior notes. The Company was in compliance with all

financial and non-financial covenants under its various loan agreements as of March 31, 2025.

Loans Payable of Consolidated Funds

Loans payable of Consolidated Funds primarily represent amounts due to holders of debt securities issued by the CLOs.

As of March 31, 2025 and December 31, 2024, the following borrowings were outstanding (Dollars in millions):

As of March 31, 2025
BorrowingOutstanding · Fair Value · WeightedAverageInterest Rate · WeightedAverageRemainingMaturity inYears
Senior secured notes$7,537.4$7,434.25.64%9.69
Subordinated notes284.7246.1N/A(2)8.81
Revolving credit facilities(1)121.4121.47.10%4.13
Total$7,943.5$7,801.7
As of December 31, 2024
BorrowingOutstanding · Fair Value · WeightedAverageInterest Rate · WeightedAverageRemainingMaturity inYears
Senior secured notes$6,732.8$6,598.85.72%9.18
Subordinated notes229.9210.3N/A(2)9.15
Revolving credit facilities(1)55.155.17.01%4.53
Total$7,017.8$6,864.2

(1)Fair Value as of March 31, 2025 and December 31, 2024 reflects the amortized cost of outstanding revolving credit balances which

approximates fair value.

(2)The subordinated notes do not have contractual interest rates, but instead receive distributions from the excess cash flows of the

CLOs.

Loans payable of the CLOs are collateralized by the assets held by the CLOs and the assets of one CLO may not be used

to satisfy the liabilities of another. This collateral consisted of cash and cash equivalents, corporate loans, corporate bonds and

other securities. As of March 31, 2025 and December 31, 2024, the fair value of the CLO assets was$8.8 billion and$7.9

billion, respectively.

  1. Accrued Compensation and Benefits

Accrued compensation and benefits consist of the following:

As of
March 31,2025December 31, 2024
(Dollars in millions)
Accrued performance allocations and incentive fee related compensation$4,751.8$4,819.7
Accrued bonuses92.9335.5
Realized performance allocations and incentive fee related compensation not yet paid109.3183.8
Other109.5107.6
Total$5,063.5$5,446.6

The following table presents realized and unrealized performance allocations and incentive fee related compensation:

Three Months Ended March 31,
20252024
(Dollars in millions)
Realized$252.9$266.8
Unrealized(81.5)(339.6)
Total$171.4$(72.8)
  1. Commitments and Contingencies

Capital Commitments

The Company and its unconsolidated affiliates have unfunded commitments totaling$4.1 billion as of March 31, 2025, of

which approximately$3.4 billion is subscribed individually by senior Carlyle professionals, advisors and other professionals. In

addition to these unfunded commitments, the Company may from time to time exercise its right to purchase additional interests

in its investment funds that become available in the ordinary course of their operations.

Under the Carlyle Global Capital Markets platform, certain subsidiaries of the Company may act as an underwriter,

syndicator or placement agent for security offerings and loan originations. The Company earns fees in connection with these

activities and bears the risk of the sale of such securities and placement of such loans, which may be longer dated. As of

March 31, 2025, the Company hadno material commitments related to the origination and syndication of loans and securities

under the Carlyle Global Capital Markets platform.

Guaranteed Loans

From time to time, the Company or its subsidiaries may enter into agreements to guarantee certain obligations of the

investment funds related to, for example, credit facilities or equity commitments. Certain consolidated subsidiaries of the

Company are the guarantors of revolving credit facilities for certain funds in the Carlyle AlpInvest segment. The guarantee is

limited to the lesser of the total amount drawn under the credit facilities or the total of net asset value of the guarantor

subsidiaries plus any uncalled capital of the applicable general partner. The outstanding balances are secured by uncalled capital

commitments from the underlying funds and the Company believes the likelihood of any material funding under this guarantee

to be remote. The Company hadno material outstanding guarantees under the credit facilities as of March 31, 2025.

Additionally, as of March 31, 2025, certain consolidated subsidiaries of the Company are the guarantors of a credit

agreement for a fund in the Carlyle AlpInvest segment, which is scheduled to expire in August 2025. The maximum potential

amount to be funded under this guarantee is$25.0 million. The outstanding balances under the credit agreement are

collateralized by the investments in the fund and the Company believes the likelihood of any material funding under this

guarantee to be remote.

Contingent Obligations (Giveback)

A liability for potential repayment of previously received performance allocations of$44.6 million at March 31, 2025

was shown as accrued giveback obligations in the condensed consolidated balance sheets, representing the giveback obligation

that would need to be paid if the funds were liquidated at their current fair values at March 31, 2025. However, the ultimate

giveback obligation, if any, generally is not paid until the end of a fund’s life or earlier if the giveback becomes fixed and early

payment is agreed upon by the fund’s partners (see Note 2, Summary of Significant Accounting Policies). The Company had

$11.5 million of unbilled receivables from former and current employees and senior Carlyle professionals as of March 31, 2025

related to giveback obligations. Any such receivables are collateralized by investments made by individual senior Carlyle

professionals and employees in Carlyle-sponsored funds. In addition,$150.8 million have been withheld from distributions of

carried interest to senior Carlyle professionals and employees for potential giveback obligations as of March 31, 2025. Such

amounts are held on behalf of the respective current and former Carlyle employees to satisfy any givebacks they may owe and

are held by entities not included in the accompanying condensed consolidated balance sheets. Current and former senior Carlyle

professionals and employees are personally responsible for their giveback obligations. As of March 31, 2025, approximately

$11.5 million of the Company’s accrued giveback obligation is the responsibility of various current and former senior Carlyle

professionals and other former limited partners of the Carlyle Holdings partnerships, and the net accrued giveback obligation

attributable to the Company is$33.1 million.

If, at March 31, 2025, all of the investments held by the Company’s Funds were deemed worthless, a possibility that

management views as remote, the amount of realized and distributed carried interest subject to potential giveback would be

$1.4 billion, on an after-tax basis where applicable, of which approximately$0.6 billion would be the responsibility of current

and former senior Carlyle professionals.

Legal Matters

In the ordinary course of business, the Company is a party to litigation, investigations, inquiries, employment-related

matters, disputes, and other potential claims. Certain of these matters are described below. The Company is not currently able to

estimate the reasonably possible amount of loss or range of loss, in excess of amounts accrued, for the matters that have not

been resolved. The Company does not believe it is probable that the outcome of any existing litigation, investigations, disputes,

or other potential claims will materially affect the Company or these financial statements in excess of amounts accrued.

The Authentix Matter

Authentix, Inc. (“Authentix”) was a majority-owned portfolio company in one of the Company’s investment funds,

Carlyle U.S. Growth Fund III, L.P. (“CGF III”). When Authentix was owned by CGF III, two of the Company’s employees

served on Authentix’s board of directors. After a lengthy sale process, Authentix was sold for an aggregate sale price of

$87.5 million. On August 7, 2020, certain of the former minority shareholders in Authentix filed suit in Delaware Chancery

Court, alleging that the Authentix board of directors, CGF III, and the Company breached various fiduciary duties by agreeing

to a sale of Authentix at an inopportune time and at a price that was too low. A trial before the Delaware Court of Chancery was

completed in early February 2024, and a decision was rendered in favor of the Company and all other defendants on all claims

on January 8, 2025. The plaintiffs appealed the decision to the Delaware Supreme Court on March 13, 2025.

The Tax Receivable Agreement Matter

The Company came into existence on January 1, 2020, when its predecessor, The Carlyle Group, L.P. (the “PTP”),

converted from a partnership into a corporation (the “Conversion”). On July 29, 2022, an alleged stockholder of the Company,

the City of Pittsburgh Comprehensive Municipal Trust Fund (the “Plaintiff”), filed suit in the Delaware Court of Chancery,

alleging a direct claim against the Company for breach of its certificate of incorporation and a derivative claim on behalf of the

Company against certain current and former officers and directors of the Company. Plaintiff challenges the receipt, by certain

officers of the PTP and certain directors of the general partner of the PTP, of a right to cash payments associated with the

elimination of a tax receivable agreement in connection with the Conversion. Plaintiff is seeking monetary damages, restitution,

and an injunction preventing the Company from making any future cash payments for the elimination of the tax receivable

agreement in connection with the Conversion. By virtue of the derivative nature of the primary claims (i.e., that the claims are

aimed primarily at certain officers and directors), it is unlikely that the Company itself will pay material damage awards based

on the Plaintiff’s claims, although the Company is expected to incur legal defense fees to the extent not covered by insurance.

The Delaware Court issued a ruling on the defendant’s motion to dismiss on April 24, 2024, dismissing some of the Plaintiff’s

claims but allowing most of the claims to proceed to discovery and possibly to trial. The Company intends to contest the direct

claims vigorously, and the officer and director defendants intend to continue contesting the derivative claims vigorously.

SEC Investigation

As part of a sweep investigation of financial services and investment advisory firms, in October 2022, the Company

received from the SEC a request for information related to the preservation of certain types of electronic business

communications (e.g., text messages and messages on WhatsApp, WeChat, and similar applications) as part of the Company’s

books and records. On January 13, 2025, the SEC announced a settlement with several of the firms that were part of the sweep

investigation, including the Company. Under the settlement, the Company paid a civil penalty of$8.5 million during the three

months ended March 31, 2025 and agreed to implement certain limited remedial measures for failure to maintain and preserve

such electronic communications in its books and records under the Advisers Act. The Company accrued for the civil penalty

during the year ended December 31, 2024.

General

The Company currently is and expects to continue to be, from time to time, subject to examinations, formal and informal

inquiries, and investigations by various U.S. and non-U.S. governmental and regulatory agencies, including but not limited to,

the SEC, Department of Justice, state attorneys general, FINRA, National Futures Association, and the U.K. Financial Conduct

Authority. The Company routinely cooperates with such examinations, inquiries and investigations, and they may result in the

commencement of civil, criminal, or administrative or other proceedings against the Company or its personnel.

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings and employment-

related matters, and some of the matters discussed above involve claims for potentially large and/or indeterminate amounts of

damages. Based on information known by management, management does not believe that as of the date of this filing the final

resolutions of the matters above will have a material effect upon the Company’s condensed consolidated financial statements.

However, given the potentially large and/or indeterminate amounts of damages sought in certain of these matters and the

inherent unpredictability of investigations and litigations, it is possible that an adverse outcome in certain matters could, from

time to time, have a material effect on the Company’s financial results in any particular period.

The Company accrues an estimated loss contingency liability when it is probable that such a liability has been incurred

and the amount of the loss can be reasonably estimated. As of March 31, 2025, the Company had recorded liabilities

aggregating to approximately$35 million for litigation-related contingencies, regulatory examinations and inquiries, and other

matters. The Company evaluates its outstanding legal and regulatory proceedings and other matters each quarter to assess its

loss contingency accruals, and makes adjustments in such accruals, upward or downward, as appropriate, based on

management’s best judgment after consultation with counsel. There is no assurance that the Company’s accruals for loss

contingencies will not need to be adjusted in the future or that, in light of the uncertainties involved in such matters, the ultimate

resolution of these matters will not significantly exceed the accruals that the Company has recorded.

Indemnifications

In the normal course of business, the Company and its subsidiaries enter into contracts that contain a variety of

representations and warranties and provide general indemnifications. The Company’s maximum exposure under these

arrangements is unknown as this would involve future claims that may be made against the Company that have not yet

occurred. However, based on experience, the Company believes the risk of material loss to be remote.

In connection with the sale of the Company’s interest in its local Brazilian management entity in August 2021, the

Company provided a guarantee to the acquiring company of up to BRL 100.0 million ($17.5 million as of March 31, 2025) for

liabilities arising from tax-related indemnifications. This guarantee, which will expire in August 2027, would only come into

effect after all alternative remedies have been exhausted. The Company believes the likelihood of any material funding under

this guarantee to be remote.

Risks and Unce rtainties

Carlyle’s funds seek investment opportunities that offer the possibility of attaining substantial capital appreciation.

Certain events particular to each industry in which the underlying investees conduct their operations, as well as general

economic, political, regulatory, and public health conditions, may have a significant negative impact on the Company’s

investments and profitability. The funds managed by the Company may also experience a slowdown in the deployment of

capital, which could adversely affect the Company’s ability to raise capital for new or successor funds and could also impact the

management fees the Company earns on its carry funds and managed accounts, and/or result in the impairment of intangible

assets and/or goodwill the case of the Company’s acquired businesses. Such events are beyond the Company’s control, and the

likelihood that they may occur and the effect on the Company cannot be predicted.

Furthermore, certain of the funds’ investments are made in private companies and there are generally no public markets

for the underlying securities at the current time. The funds’ ability to liquidate their publicly-traded investments are often

subject to limitations, including discounts that may be required to be taken on quoted prices due to the number of shares being

sold. The funds’ ability to liquidate their investments and realize value is subject to significant limitations and uncertainties,

including among others currency fluctuations and natural disasters.

The Company and the funds make investments outside of the United States. Investments outside the United States may be

subject to less developed bankruptcy, corporate, partnership and other laws (which may have the effect of disregarding or

otherwise circumventing the limited liability structures potentially causing the actions or liabilities of one fund or a portfolio

company to adversely impact the Company or an unrelated fund or portfolio company). Non-U.S. investments are subject to the

same risks associated with the Company’s U.S. investments as well as additional risks, such as fluctuations in foreign currency

exchange rates, unexpected changes in regulatory requirements, heightened risk of political and economic instability,

difficulties in managing non-U.S. investments, potentially adverse tax consequences and the burden of complying with a wide

variety of foreign laws.

Furthermore, Carlyle is exposed to economic risk concentrations related to certain large investments as well as

concentrations of investments in certain industries and geographies.

Additionally, the Company encounters credit risk. Credit risk is the risk of default by a counterparty in the Company’s

investments in debt securities, loans, leases and derivatives that result from a borrower’s, lessee’s or derivative counterparty’s

inability or unwillingness to make required or expected payments. The Company is subject to credit risk should a financial

institution be unable to fulfill its obligations.

The Company considers cash, cash equivalents, securities, receivables, principal equity method investments, accounts

payable, accrued expenses, other liabilities, loans, senior notes, assets and liabilities of Consolidated Funds and contingent and

other consideration for acquisitions to be its financial instruments. Except for the senior notes, subordinated notes and

compensatory contingent and other consideration for acquisitions, the carrying amounts reported in the condensed consolidated

balance sheets for these financial instruments equal or closely approximate their fair values. The fair value of the senior and

subordinated notes is disclosed in Note 6, Borrowings.

  1. Related Party Transactions

Due from Affiliates and Other Receivables, Net

The Company had the following due from affiliates and other receivables at March 31, 2025 and December 31, 2024:

As of
March 31,2025December 31, 2024
(Dollars in millions)
Accrued incentive fees$38.7$33.7
Unbilled receivable for giveback obligations from current and former employees11.511.5
Notes receivable and accrued interest from affiliates56.546.2
Management fee receivable, net268.9296.4
Reimbursable expenses and other receivables from unconsolidated funds and affiliates, net414.6417.8
Total$790.2$805.6

Reimbursable expenses and other receivables from certain of the unconsolidated funds and portfolio companies relate to

advisory fees receivable and expenses paid on behalf of these entities. These costs generally represent costs related to the

pursuit of actual or proposed investments, professional fees and expenses associated with the acquisition, holding and

disposition of the investments. The affiliates are obligated at the discretion of the Company to reimburse the expenses. Based

on management’s determination, the Company accrues and charges interest on amounts due from affiliate accounts at interest

rates ranging up to 7.02% as of March 31, 2025. The accrued and charged interest to the affiliates was not significant for any

period presented.

Notes receivable includes loans that the Company has provided to certain unconsolidated funds to meet short-term

obligations to purchase investments. Notes receivable as of March 31, 2025 and December 31, 2024 also include interest-

bearing loans of$21.7 million and$22.8 million, respectively, to certain eligible Carlyle employees, which excludes Section 16

officers and other members of senior management, to finance their investments in certain Carlyle sponsored funds. These

advances accrue interest at the WSJPrime Rate minus 1.00% floating with a floor rate of 3.50% (6.50% as of March 31, 2025)

and are collateralized by each borrower’s interest in the Carlyle sponsored funds.

These receivables are assessed regularly for collectability. Management fee receivable amounts determined to be

uncollectible are recorded as a reduction in revenue in the condensed consolidated statements of operations. For all other

receivables, amounts determined to be uncollectible are charged directly to general, administrative and other expenses in the

condensed consolidated statements of operations. A corresponding allowance for doubtful accounts is recorded and such

amounts were not significant for any period presented.

Due to Affiliates

The Company had the following due to affiliates balances at March 31, 2025 and December 31, 2024:

As of
March 31,2025December 31, 2024
(Dollars in millions)
Due to affiliates of Consolidated Funds$55.5$5.3
Due to non-consolidated affiliates138.1134.1
Amounts owed under the tax receivable agreement71.677.2
Other27.625.3
Total$292.8$241.9

The Company has recorded obligations for amounts due to certain of its affiliates. The Company periodically offsets

expenses it has paid on behalf of its affiliates against these obligations.

In connection with the Company’s initial public offering, the Company entered into a tax receivable agreement with the

limited partners of the Carlyle Holdings partnerships whereby certain subsidiaries of the Partnership agreed to pay to the limited

partners of the Carlyle Holdings partnerships involved in any exchange transaction 85% of the amount of cash tax savings, if

any, in U.S. federal, state and local income tax realized as a result of increases in tax basis resulting from exchanges of Carlyle

Holdings Partnership units for common units of The Carlyle Group L.P.

Other Related Party Transactions

Aircraft Transactions

Entities controlled by our co-founders own aircraft that may be used for the Company’s business in the ordinary course of

its operations. The hourly rates that the Company pays for the use of these aircraft are based on current market rates for

chartering private aircraft of the same type. The Company incurred$0.4 million for the use of these aircraft for thethree months

ended March 31, 2025, all of which was paid directly to the manager of the aircraft and a significant portion of which ultimately

was paid to or for the benefit of certain co-founders.

BDC Preferred Shares

On May 5, 2020, the Company purchased 2,000,000 of the BDC Preferred Shares from CGBD in a private placement at a

price of$25 per share. Prior to the Exchange, as discussed below, dividends were payable on a quarterly basis in an initial

amount equal to 7.0% per annum payable in cash, or, at CGBD’s option,9.0% per annum payable in additional BDC Preferred

Shares. The BDC Preferred Shares were convertible at the Company’s option, in whole or in part, into the number of shares of

common stock equal to$25 per share plus any accumulated but unpaid dividends divided by an initial conversion price of$9.50

per share, subject to certain adjustments.

In August 2024, to facilitate a merger between CGBD and another Carlyle-advised BDC (the “Merger”), the Company

agreed to exchange its 2,000,000 preferred shares into newly issued common shares of CGBD at a price equal to the net asset

value per common share on the date of completion of the Merger(the “Exchange”). The Merger and the Exchange were

completed on March 27, 2025, and the Company exchanged its preferred shares for 3,004,808 newly issued common shares of

CGBD based on the net asset value of$16.64 per common share of CGBD on that date. The preferred shares were cancelled

following the completion of the Exchange. The newly issued common shares of CGBD are subject to a tiered lock-up

agreement with a restriction period that expires in three equal tranches of the common shares over a period oftwo years.

For thethree months ended March 31, 2025 and 2024, the Company recorded dividend income from the BDC Preferred

Shares of$0.8 million and$0.9 million, respectively, which was included in Interest and other income in the condensed

consolidated statements of operations. The Company’s investment in the common shares of CGBD, which was recorded at fair

value using Level I inputs based on the CGBD common share price, was$48.6 million as of March 31, 2025, and was included

in Investments, including accrued performance allocations, in the condensed consolidated balance sheets. The Company’s

investment in the BDC Preferred Shares, which was recorded at fair value using Level III inputs based on the estimated

conversion value, was$53.4 million as of December 31, 2024, and was included in Investments, including accrued performance

allocations, in the condensed consolidated balance sheets.

Other Transactions

Senior Carlyle professionals and employees are permitted to participate in co-investment entities that invest in Carlyle

funds or alongside Carlyle funds. In many cases, participation is limited by law to individuals who qualify under applicable

legal requirements. These co-investment entities generally do not require senior Carlyle professionals and employees to pay

management or performance allocations, however, Carlyle professionals and employees are required to pay their portion of

partnership expenses.

Carried interest income from certain funds can be distributed to senior Carlyle professionals and employees on a current

basis, but is subject to repayment by the subsidiary of the Company that acts as general partner of the fund in the event that

certain specified return thresholds are not ultimately achieved. The senior Carlyle professionals and certain other investment

professionals have personally guaranteed, subject to certain limitations, the obligation of these subsidiaries in respect of this

general partner obligation. Such guarantees are several and not joint and are limited to a particular individual’s distributions

received.

The Company does business with some of its portfolio companies; all such arrangements are on a negotiated basis.

Substantially all revenue is earned from affiliates of Carlyle.

  1. Income Taxes

The Company’s provision for income taxes was$12.4 million and$21.9 million for thethree months ended March 31,

2025 and 2024, respectively. The Company’s effective tax rate was approximately 7% and 18% for thethree months ended

March 31, 2025 and 2024, respectively. The effective tax rate for thethree months ended March 31, 2025 primarily comprised

the 21% U.S. federal corporate income tax rate and disallowed executive compensation, primarily offset by a benefit related to

equity-based compensation deductions and non-controlling interest. The effective tax rate for thethree months ended March 31,

2024 primarily comprised the 21% U.S. federal corporate income tax rate and disallowed executive compensation, partially

offset by non-controlling interest and foreign income taxes. As of March 31, 2025 and December 31, 2024, the Company had

federal, state, local and foreign taxes payable of$70.4 million and$46.2 million, respectively, which is recorded as a

component of accounts payable, accrued expenses and other liabilities on the accompanying condensed consolidated balance

sheets.

In the normal course of business, the Company is subject to examination by federal and certain state, local and foreign tax

regulators. With a few exceptions, as of March 31, 2025, the Company’s U.S. federal income tax returns for the years 2021

through 2023 are open under the normal three-year statute of limitations and therefore subject to examination. State and local

tax returns are generally subject to audit from 2019 to 2023. Foreign tax returns are generally subject to audit from 2011 to

  1. Certain of the Company’s affiliates are currently under audit by federal, state and foreign tax authorities.

The Company does not believe that the outcome of the audits will require it to record material reserves for uncertain tax

positions or that the outcome will have a material impact on the condensed consolidated financial statements. The Company

does not believe that it has any tax positions for which it is reasonably possible that the total amounts of unrecognized tax

benefits will significantly increase or decrease within thenext twelve months.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IRA”) was signed into law. The IRA enacted a 15%

CAMT on the “adjusted financial statement income” of certain large corporations, which became effective on January 1, 2023.

The Company does not expect the IRA to have a material impact to its provision for income taxes given that any current year

payments that would be made under CAMT would be permitted to be carried forward and used as credits in future years

resulting in a deferred tax benefit. The Company will continue to monitor as additional guidance is released by U.S. Department

of the Treasury, the Internal Revenue Service, and other standard-setting bodies.

On December 27, 2023, the State of New York issued final regulations that implemented comprehensive franchise tax

reform for corporations, banks, and insurance companies. This did not have a material impact to the Company’s condensed

consolidated financial statements. The Company will continue to monitor as additional guidance is released by the State of New

York.

In October 2021, the OECD introduced a 15% global minimum tax under the Pillar Two GloBE model rules. There are a

number of key provisions under the rules that became effective in 2024 and others that will be phased in during 2025. Several

OECD member countries have enacted the tax legislation based on certain elements of these rules that became effective on

January 1, 2024, and additional countries have drafted or announced an intent to implement legislation. While Pillar Two has

not had a material impact to the Company’s provision for income taxes, the rules remain subject to significant negotiation and

potential change, and the timing and ultimate impact of any such changes on our tax obligations are uncertain. The Company

will continue to monitor as additional countries enact legislation, new parts of the regime come into force or additional

guidance is released by the OECD and other standard-setting bodies.

  1. Non-controlling Interests in Consolidated Entities

The components of the Company’s non-controlling interests in consolidated entities are as follows:

As of
March 31, 2025December 31, 2024
(Dollars in millions)
Non-Carlyle interests in Consolidated Funds$408.6$407.1
Non-Carlyle interests in majority-owned subsidiaries399.6334.2
Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions(0.4)(0.6)
Non-controlling interests in consolidated entities$807.8$740.7

The components of the Company’s non-controlling interests in income of consolidated entities are as follows:

Three Months EndedMarch 31,
20252024
(Dollars in millions)
Non-Carlyle interests in Consolidated Funds$8.0$12.7
Non-Carlyle interests in majority-owned subsidiaries20.620.5
Non-controlling interests in income of consolidated entities$28.6$33.2
  1. Earnings Per Common Share

Basic and diluted net income per common share are calculated as follows:

Three Months EndedMarch 31, 2025
BasicDiluted
Net income attributable to common shares$130,000,000$130,000,000
Weighted-average common shares outstanding359,464,272366,336,892
Net income per common share$0.36$0.35
Three Months EndedMarch 31, 2024
BasicDiluted
Net income attributable to common shares$65,600,000$65,600,000
Weighted-average common shares outstanding360,908,247369,343,601
Net income per common share$0.18$0.18

The weighted-average common shares outstanding, basic and diluted, are calculated as follows:

Three Months EndedMarch 31, 2025
BasicDiluted
The Carlyle Group Inc. weighted-average common shares outstanding359,464,272359,464,272
Unvested restricted stock units—6,182,260
Issuable common shares and performance-vesting restricted stock units—690,360
Weighted-average common shares outstanding359,464,272366,336,892
Three Months EndedMarch 31, 2024
BasicDiluted
The Carlyle Group Inc. weighted-average common shares outstanding360,908,247360,908,247
Unvested restricted stock units—6,733,282
Issuable common shares and performance-vesting restricted stock units—1,702,072
Weighted-average common shares outstanding360,908,247369,343,601

The Company applies the treasury stock method to determine the dilutive weighted-average common shares represented

by the unvested restricted stock units. Also included in the determination of dilutive weighted-average common shares are

issuable common shares associated with the Company’s investment in NGP and performance-vesting restricted stock units.

  1. Equity

Share Repurchase Program

The Board of Directors reset the total repurchase authorization of the Company’s previously approved share repurchase

program to$1.4 billion in shares of the Company’s common stock, effective as of February 6, 2024. Under the share repurchase

program, shares of the Company’s common stock may be repurchased from time to time in open market transactions, in

privately negotiated transactions, or otherwise, including through Rule 10b5-1 plans. The timing and actual number of shares of

common stock repurchased will depend on a variety of factors, including legal requirements and price, economic, and market

conditions. In addition to repurchases of common stock, the share repurchase program is used for the payment of tax

withholding amounts upon net share settlement of equity-based awards granted pursuant to our Equity Incentive Plan or

otherwise based on the value of shares withheld that would have otherwise been issued to the award holder. The share

repurchase program may be suspended or discontinued at any time and does not have a specified expiration date. As of

March 31, 2025,$675.6 million of repurchase capacity remained under the program, which reflects both common shares

repurchased and shares retired in connection with the net share settlement of equity-based awards. The following table presents

the Company’s shares that have been repurchased or retired as a result of net share settlement of equity-based awards during the

three months ended March 31, 2025 and 2024. Dollar amounts exclude the impact of excise taxes.

Three Months Ended March 31,
20252024
Shares$Shares$
(Dollars in millions, except share data)
Shares repurchased493,781$25.02,853,602$130.6
Shares retired in connection with the net share settlement of equity-based awards2,835,354151.5481,26119.4
Total3,329,135$176.53,334,863$150.0

Dividends

The table below presents information regarding the quarterly dividends on the common shares, which were made at the

sole discretion of the Board of Directors of the Company.

Dividend Record DateDividend Payment DateDividend per Common ShareDividend to Common Stockholders
(Dollars in millions, except per share data)
May 14, 2024May 21, 2024$0.35$125.6
August 16, 2024August 26, 20240.35125.5
November 18, 2024November 25, 20240.35125.2
February 21, 2025February 28, 20250.35126.4
Total 2024 Dividend Year$1.40$502.7
May 19, 2025May 27, 2025$0.35$126.4
Total 2025 Dividend Year (through Q1 2025)$0.35$126.4

The Board of Directors will take into account general economic and business conditions, as well as the Company’s

strategic plans and prospects, business and investment opportunities, financial condition and obligations, legal, tax and

regulatory restrictions, other constraints on the payment of dividends by the Company to its common stockholders or by

subsidiaries to the Company, and other such factors as the Board of Directors may deem relevant. In addition, the terms of the

Company’s credit facility provide certain limits on the Company’s ability to pay dividends.

  1. Equity-Based Compensation

The Carlyle Group Inc. Amended and Restated 2012 Equity Incentive Plan (the “Equity Incentive Plan,” initially adopted

in May 2012 and as most recently amended and restated on May 29, 2024) is a source of equity-based awards permitting the

Company to grant to Carlyle employees, directors and consultants non-qualified options, share appreciation rights, common

shares, restricted stock units and other awards based on the Company’s shares of common stock. A total of 58,800,000 shares of

common stock are authorized for the grant of awards under the Equity Incentive Plan, of which a total of 26,170,858 shares of

the Company’s common stock remain available for grant as of March 31, 2025.

A summary of the status of the Company’s non-vested equity-based awards as of March 31, 2025 and a summary of

changes for thethree months ended March 31, 2025, are presented below:

Unvested SharesPerformance-Vesting Restricted Stock UnitsWeighted-AverageGrant DateFair ValueRestrictedStockUnitsWeighted-AverageGrant DateFair ValueUnvestedCommonSharesWeighted-AverageGrant DateFair Value
Balance, December 31, 202416,940,150$25.4113,966,488$37.97458,906$39.35
Granted (1)397,196$34.424,463,972$56.10171,891$56.33
Vested (2)5,362,679$30.831,664,507$32.26—$—
Forfeited359,053$23.37143,066$39.65—$—
Balance, March 31, 202511,615,614$23.2816,622,887$43.40630,797$43.63

(1)Includes shares reserved for issuance upon settlement of dividend-equivalent rights carried by certain restricted stock units concurrently

with the settlement of the restricted stock units for shares.

(2)Includes 2,835,354 shares that were retired in connection with the net share settlement of equity-based awards. The Company paid

$151.5 million of taxes related to the net share settlement of equity-based awards during thethree months ended March 31, 2025, which

is included within financing activities in the condensed consolidated statements of cash flows.

The Company recorded equity-based compensation expense, net of forfeitures, for restricted stock units of$103.5 million

and$108.3 million for thethree months ended March 31, 2025 and 2024, respectively, with$18.6 million and$20.1 million of

corresponding deferred tax benefits, respectively. As of March 31, 2025, the total unrecognized equity-based compensation

expense related to unvested restricted stock units was$640.6 million, which is expected to be recognized over a weighted-

average term of 2.2 years.

  1. Segment Reporting

Carlyle conducts its operations through three reportable segments:

Global Private Equity – The Global Private Equity segment advises the Company’s buyout, growth, real estate,

infrastructure, and natural resources funds. The segment also includes the NGP Carry Funds advised by NGP.

Global Credit – The Global Credit segment advises funds and vehicles that pursue investment strategies including

insurance solutions, liquid credit, opportunistic credit, direct lending, asset-backed finance, aviation finance,

infrastructure credit, cross-platform credit products, and global capital markets.

Carlyle AlpInvest – The Carlyle AlpInvest segment advises global private equity programs that pursue secondary

purchases and financing of existing portfolios, managed co-investment programs, and primary fund investments.

The Company’s reportable business segments are differentiated by their various investment focuses and strategies.

Overhead costs are generally allocated based on cash-based compensation and benefits expense for each segment. The

Company’s earnings from its investment in NGP are presented in the respective operating captions within the Global Private

Equity segment.

Distributable Earnings. Distributable Earnings, or “DE,” is a key performance benchmark used in the Company’s

industry and is evaluated regularly by the chief operating decision maker (“CODM”), which is our Chief Executive Officer, in

making resource deployment and compensation decisions and in assessing performance of the Company’sthree reportable

segments. The CODM also uses DE in budgeting, forecasting, and the overall management of the Company’s segments. The

CODM believes that reporting DE is helpful to understanding the Company’s business and that investors should review the

same supplemental financial measure that the CODM uses to analyze the Company’s segment performance. DE is intended to

show the amount of net realized earnings without the effects of the consolidation of the Consolidated Funds. DE is derived from

the Company’s segment reported results and is used to assess performance.

Distributable Earnings differs from income (loss) before provision for income taxes computed in accordance with U.S.

GAAP in that it includes certain tax expenses associated with certain foreign performance revenues (composed of performance

allocations and incentive fees), and does not include unrealized performance allocations and related compensation expense,

unrealized principal investment income, equity-based compensation expense, net income (loss) attributable to non-Carlyle

interests in consolidated entities, or charges (credits) related to Carlyle corporate actions and non-recurring items that affect

period-to-period comparability and are not reflective of the Company’s operational performance. Charges (credits) related to

Carlyle corporate actions and non-recurring items include: charges associated with the Conversion, charges (credits) associated

with acquisitions, dispositions or strategic investments, changes in the tax receivable agreement liability, amortization and any

impairment charges associated with acquired intangible assets, transaction costs associated with acquisitions and dispositions,

charges associated with earn-outs and contingent consideration including gains and losses associated with the estimated fair

value of contingent considerations issued in conjunction with acquisitions or strategic investments, impairment charges

associated with lease right-of-use assets, gains and losses from the retirement of debt, charges associated with contract

terminations and employee severance, and non-recurring items that affect period-to-period comparability and are not reflective

of the Company’s operating performance. Management believes the inclusion or exclusion of these items provides investors

with a meaningful indication of the Company’s core operating performance.

Fee Related Earnings. Fee Related Earnings, or “FRE,” is a component of DE and is used to assess the ability of the

business to cover base compensation and operating expenses from total fee revenues. FRE adjusts DE to exclude net realized

performance revenues, realized principal investment income, and net interest (interest income less interest expense). Fee

Related Earnings includes fee related performance revenues and related compensation expense. Fee related performance

revenues represent the realized portion of performance revenues that are measured and received on a recurring basis, are not

dependent on realization events, and which have no risk of giveback.

Asset information by segment is not disclosed because this information is not used by the CODM to make resource

deployment decisions or evaluate the performance of the Company’s segments.

The following tables present the financial data for the Company’sthree reportable segments for thethree months ended

March 31, 2025:

Three Months Ended March 31, 2025
GlobalPrivateEquityGlobalCreditCarlyle AlpInvestTotal
(Dollars in millions)
Segment Revenues
Fund level fee revenues
Fund management fees$283.0$139.6$102.9$525.5
Portfolio advisory and transaction fees, net and other14.563.4—77.9
Fee related performance revenues—28.810.739.5
Total fund level fee revenues297.5231.8113.6642.9
Realized performance revenues317.113.324.7355.1
Realized principal investment income15.15.59.430.0
Interest income6.07.02.215.2
Total revenues635.7257.6149.91,043.2
Segment Expenses
Compensation and benefits
Cash-based compensation and benefits100.789.034.3224.0
Realized performance revenues related compensation200.47.919.4227.7
Total compensation and benefits301.196.953.7451.7
General, administrative, and other indirect expenses(1)48.735.011.995.6
Depreciation and amortization expense6.93.91.912.7
Interest expense13.411.33.127.8
Total expenses370.1147.170.6587.8
(=) Distributable Earnings$265.6$110.5$79.3$455.4
(-) Realized Net Performance Revenues116.75.45.3127.4
(-) Realized Principal Investment Income15.15.59.430.0
(+) Net Interest7.44.30.912.6
(=) Fee Related Earnings$141.2$103.9$65.5$310.6

(1)General, administrative, and other indirect expenses primarily comprised professional fees, rent and other office expenses, IT expenses, travel and

entertainment expenses, and fundraising costs.

The following tables present the financial data for the Company’sthree reportable segments for thethree months ended

March 31, 2024:

Three Months Ended March 31, 2024
GlobalPrivateEquityGlobalCreditCarlyle AlpInvestTotal
(Dollars in millions)
Segment Revenues
Fund level fee revenues
Fund management fees$304.6$136.9$74.1$515.6
Portfolio advisory and transaction fees, net and other7.119.6—26.7
Fee related performance revenues3.724.21.229.1
Total fund level fee revenues315.4180.775.3571.4
Realized performance revenues373.80.623.4397.8
Realized principal investment income18.913.81.033.7
Interest income7.610.71.820.1
Total revenues715.7205.8101.51,023.0
Segment Expenses
Compensation and benefits
Cash-based compensation and benefits109.376.828.2214.3
Realized performance revenues related compensation234.30.321.2255.8
Total compensation and benefits343.677.149.4470.1
General, administrative, and other indirect expenses(1)38.629.611.579.7
Depreciation and amortization expense6.43.11.611.1
Interest expense14.013.92.930.8
Total expenses402.6123.765.4591.7
(=) Distributable Earnings$313.1$82.1$36.1$431.3
(-) Realized Net Performance Revenues139.50.32.2142.0
(-) Realized Principal Investment Income18.913.81.033.7
(+) Net Interest6.43.21.110.7
(=) Fee Related Earnings$161.1$71.2$34.0$266.3

(1)General, administrative, and other indirect expenses primarily comprised professional fees, rent and other office expenses, IT expenses, travel and

entertainment expenses, and fundraising costs.

The following tables reconcile the Total Segments to the Company’s Income (Loss) Before Provision for Taxes for the

three months ended March 31, 2025 and 2024.

Three Months Ended March 31, 2025
Total Reportable SegmentsConsolidated FundsReconciling ItemsCarlyle Consolidated
(Dollars in millions)
Revenues$1,043.2$133.4$(203.5)(a)$973.1
Expenses$587.8$130.8$89.6(b)$808.2
Other income (loss)$—$6.1$—(c)$6.1
Distributable earnings$455.4$8.7$(293.1)(d)$171.0
Three Months Ended March 31, 2024
Total Reportable SegmentsConsolidated FundsReconciling ItemsCarlyle Consolidated
(Dollars in millions)
Revenues$1,023.0$164.9$(499.5)(a)$688.4
Expenses$591.7$139.5$(170.5)(b)$560.7
Other income (loss)$—$(7.0)$—(c)$(7.0)
Distributable earnings$431.3$18.4$(329.0)(d)$120.7

(a)The Revenues adjustment principally represents unrealized performance revenues, unrealized principal investment

income (loss) (including Fortitude), revenues earned from the Consolidated Funds which were eliminated in

consolidation to arrive at the Company’s total revenues, adjustments for amounts attributable to non-controlling

interests in consolidated entities, adjustments related to expenses associated with the investments in NGP Management

and its affiliates that are included in operating captions or are excluded from the segment results, adjustments to reflect

the reimbursement of certain costs incurred on behalf of Carlyle funds on a net basis, and the inclusion of tax expenses

associated with certain foreign performance revenues, as detailed below:

Three Months EndedMarch 31,
20252024
(Dollars in millions)
Unrealized performance and fee related performance revenues$(197.3)$(521.6)
Unrealized principal investment income (loss)17.04.4
Adjustments related to expenses associated with investments in NGP Management and its affiliates(96.1)(3.2)
Non-controlling interests and other adjustments to present certain costs on a net basis91.041.5
Elimination of revenues of Consolidated Funds(18.1)(20.6)
$(203.5)$(499.5)

The following table reconciles the total segments fund level fee revenue to the most directly comparable U.S. GAAP

measure, the Company’s consolidated fund management fees, for thethree months ended March 31, 2025 and 2024.

Three Months EndedMarch 31,
20252024
(Dollars in millions)
Total Reportable Segments - Fund level fee revenues$642.9$571.4
Adjustments(1)(56.8)(47.8)
Carlyle Consolidated - Fund management fees$586.1$523.6

(1)Adjustments represent the reclassification of NGP management fees from principal investment income, the

reclassification of fee related performance revenues from business development companies and other products,

management fees earned from Consolidated Funds which were eliminated in consolidation to arrive at the

Company’s fund management fees, and the reclassification of certain amounts included in portfolio advisory

fees, net and other in the segment results that are included in interest and other income in the U.S. GAAP results.

(b)The Expenses adjustment represents the elimination of intercompany expenses of the Consolidated Funds payable to the

Company, the inclusion of equity-based compensation, certain tax expenses associated with realized performance

revenues related compensation, and unrealized performance revenues related compensation, adjustments related to

expenses associated with the investment in NGP Management that are included in operating captions, adjustments to

reflect the reimbursement of certain costs incurred on behalf of Carlyle funds on a net basis, changes in the tax

receivable agreement liability, and charges and credits associated with Carlyle corporate actions and non-recurring

items, as detailed below:

Three Months Ended March 31,
20252024
(Dollars in millions)
Unrealized performance and fee related performance revenue compensation expense$(107.3)$(328.4)
Equity-based compensation104.7111.0
Acquisition or disposition-related charges and amortization of intangibles and impairment122.232.8
Tax (expense) benefit associated with certain foreign performance revenues related compensation—(1.0)
Non-controlling interests and other adjustments to present certain costs on a net basis(25.7)17.8
Other adjustments13.112.2
Elimination of expenses of Consolidated Funds(17.4)(14.9)
$89.6$(170.5)

(c)The Other Income (Loss) adjustment results from the Consolidated Funds that were eliminated in consolidation to

arrive at the Company’s total Other Income (Loss).

(d)The following table is a reconciliation of Income (Loss) Before Provision for Income Taxes to Distributable Earnings

and to Fee Related Earnings:

Three Months Ended March 31,
20252024
(Dollars in millions)
Income (loss) before provision for income taxes$171.0$120.7
Adjustments:
Net unrealized performance and fee related performance revenues90.0193.2
Unrealized principal investment (income) loss(17.0)(4.4)
Equity-based compensation(1)104.7111.0
Acquisition or disposition-related charges, including amortization of intangibles and impairment122.232.8
Tax (expense) benefit associated with certain foreign performance revenues—(1.0)
Net income attributable to non-controlling interests in consolidated entities(28.6)(33.2)
Other adjustments(2)13.112.2
Distributable Earnings$455.4$431.3
Realized performance revenues, net of related compensation(3)127.4142.0
Realized principal investment income(3)30.033.7
Net interest12.610.7
Fee Related Earnings$310.6$266.3

(1)Equity-based compensation for thethree months ended March 31, 2025 and 2024 included amounts that are presented in

principal investment income and general, administrative and other expenses in the Company’s condensed consolidated

statements of operations.

(2)Includes charges (credits) related to Carlyle corporate actions and non-recurring items that affect period-to-period

comparability and are not reflective of the Company’s operating performance.

(3)See reconciliation to most directly comparable U.S. GAAP measure below:

Three Months Ended March 31, 2025
CarlyleConsolidatedAdjustments (4)TotalReportableSegments
(Dollars in millions)
Performance revenues$222.9$132.2$355.1
Performance revenues related compensation expense171.456.3227.7
Net performance revenues$51.5$75.9$127.4
Principal investment income (loss)$(63.1)$93.1$30.0
Three Months Ended March 31, 2024
CarlyleConsolidatedAdjustments (4)TotalReportableSegments
(Dollars in millions)
Performance revenues$(157.0)$554.8$397.8
Performance revenues related compensation expense(72.8)328.6255.8
Net performance revenues$(84.2)$226.2$142.0
Principal investment income (loss)$73.1$(39.4)$33.7

(4) Adjustments to performance revenues and principal investment income (loss) relate to (i) unrealized performance allocations

net of related compensation expense and unrealized principal investment income, which are excluded from the segment

results, (ii) amounts earned from the Consolidated Funds, which were eliminated in the U.S. GAAP consolidation but were

included in the segment results, (iii) amounts attributable to non-controlling interests in consolidated entities, which were

excluded from the segment results, (iv) the reclassification of NGP performance revenues, which are included in principal

investment income in the U.S. GAAP financial statements, (v) the reclassification of fee related performance revenues, which

are included in fund level fee revenues in the segment results, and (vi) the reclassification of tax expenses associated with

certain foreign performance revenues. Adjustments to principal investment income (loss) also include the reclassification of

earnings for the investments in NGP Management and its affiliates to the appropriate operating captions for the segment

results, the exclusion of charges associated with the investment in NGP Management and its affiliates that are excluded from

the segment results and the exclusion of the principal investment loss from dilution of the indirect investment in Fortitude.

  1. Subsequent Events

In April, the Company’s Board of Directors declared a quarterly dividend of$0.35 per share of common stock to

common stockholders of record at the close of business on May 19, 2025, payable on May 27, 2025.

  1. Supplemental Financial Information

The following supplemental financial information illustrates the consolidating effects of the Consolidated Funds on the

Company’s financial position as of March 31, 2025 and December 31, 2024 and results of operations for thethree months

ended March 31, 2025 and 2024. The supplemental statement of cash flows is presented without effects of the Consolidated

Funds.

As of March 31, 2025
ConsolidatedOperatingEntitiesConsolidatedFundsEliminationsConsolidated
(Dollars in millions)
Assets
Cash and cash equivalents$1,190.3$—$—$1,190.3
Cash and cash equivalents held at Consolidated Funds—570.9—570.9
Restricted cash9.0——9.0
Investments, including accrued performance allocations of $6,985.811,331.5—(591.6)10,739.9
Investments of Consolidated Funds—9,329.8—9,329.8
Due from affiliates and other receivables, net1,083.99.0(302.7)790.2
Due from affiliates and other receivables of Consolidated Funds, net—228.3—228.3
Fixed assets, net188.2——188.2
Lease right-of-use assets, net356.1——356.1
Deposits and other65.61.8—67.4
Intangible assets, net603.2——603.2
Deferred tax assets22.2——22.2
Total assets$14,850.0$10,139.8$(894.3)$24,095.5
Liabilities and equity
Debt obligations$2,156.1$—$—$2,156.1
Loans payable of Consolidated Funds—8,097.5(295.8)7,801.7
Accounts payable, accrued expenses and other liabilities367.1——367.1
Accrued compensation and benefits5,063.5——5,063.5
Due to affiliates237.355.5—292.8
Deferred revenue421.5——421.5
Deferred tax liabilities106.0——106.0
Other liabilities of Consolidated Funds—956.0(0.1)955.9
Lease liabilities501.1——501.1
Accrued giveback obligations44.6——44.6
Total liabilities8,897.29,109.0(295.9)17,710.3
Common stock3.6——3.6
Additional paid-in capital3,997.7623.6(623.6)3,997.7
Retained earnings1,864.8——1,864.8
Accumulated other comprehensive loss(312.5)(1.4)25.2(288.7)
Non-controlling interests in consolidated entities399.2408.6—807.8
Total equity5,952.81,030.8(598.4)6,385.2
Total liabilities and equity$14,850.0$10,139.8$(894.3)$24,095.5
As of December 31, 2024
ConsolidatedOperatingEntitiesConsolidatedFundsEliminationsConsolidated
(Dollars in millions)
Assets
Cash and cash equivalents$1,266.0$—$—$1,266.0
Cash and cash equivalents held at Consolidated Funds—830.4—830.4
Restricted cash0.5——0.5
Investments, including accrued performance allocations of $7,053.511,324.1—(387.4)10,936.7
Investments of Consolidated Funds—7,782.4—7,782.4
Due from affiliates and other receivables, net1,111.0—(305.4)805.6
Due from affiliates and other receivables of Consolidated Funds, net—237.1—237.1
Fixed assets, net185.3——185.3
Lease right-of-use assets, net341.4——341.4
Deposits and other54.61.8—56.4
Intangible assets, net634.1——634.1
Deferred tax assets27.6——27.6
Total assets$14,944.6$8,851.7$(692.8)$23,103.5
Liabilities and equity
Debt obligations$2,143.5$—$—$2,143.5
Loans payable of Consolidated Funds—7,161.6(297.4)6,864.2
Accounts payable, accrued expenses and other liabilities389.8——389.8
Accrued compensation and benefits5,446.6——5,446.6
Due to affiliates236.65.3—241.9
Deferred revenue138.7——138.7
Deferred tax liabilities137.0——137.0
Other liabilities of Consolidated Funds—861.7(0.1)861.6
Lease liabilities488.6——488.6
Accrued giveback obligations44.0——44.0
Total liabilities9,024.88,028.6(297.5)16,755.9
Common stock3.6——3.6
Additional paid-in capital3,892.3423.5(423.5)3,892.3
Retained earnings2,040.8——2,040.8
Accumulated other comprehensive loss(350.5)(7.5)28.2(329.8)
Non-controlling interests in consolidated entities333.6407.1—740.7
Total equity5,919.8823.1(395.3)6,347.6
Total liabilities and equity$14,944.6$8,851.7$(692.8)$23,103.5
Three Months Ended March 31, 2025
ConsolidatedOperatingEntitiesConsolidatedFundsEliminationsConsolidated
(Dollars in millions)
Revenues
Fund management fees$594.4$—$(8.3)$586.1
Incentive fees43.3—(0.1)43.2
Investment income
Performance allocations223.4—(0.5)222.9
Principal investment income(60.5)—(2.6)(63.1)
Total investment income162.9—(3.1)159.8
Interest and other income57.2—(6.6)50.6
Interest and other income of Consolidated Funds—133.4—133.4
Total revenues857.8133.4(18.1)973.1
Expenses
Compensation and benefits
Cash-based compensation and benefits218.4——218.4
Equity-based compensation103.5——103.5
Performance allocations and incentive fee related compensation171.4——171.4
Total compensation and benefits493.3——493.3
General, administrative and other expenses173.7—(0.1)173.6
Interest27.8——27.8
Interest and other expenses of Consolidated Funds—130.8(17.3)113.5
Total expenses694.8130.8(17.4)808.2
Other income
Net investment income of Consolidated Funds—6.1—6.1
Income before provision for income taxes163.08.7(0.7)171.0
Provision for income taxes12.4——12.4
Net income150.68.7(0.7)158.6
Net income attributable to non-controlling interests in consolidated entities20.6—8.028.6
Net income attributable to The Carlyle Group Inc.$130.0$8.7$(8.7)$130.0
Three Months Ended March 31, 2024
ConsolidatedOperatingEntitiesConsolidatedFundsEliminationsConsolidated
(Dollars in millions)
Revenues
Fund management fees$530.2$—$(6.6)$523.6
Incentive fees26.2——26.2
Investment income (loss)
Performance allocations(155.8)—(1.2)(157.0)
Principal investment income79.6—(6.5)73.1
Total investment loss(76.2)—(7.7)(83.9)
Interest and other income63.9—(6.3)57.6
Interest and other income of Consolidated Funds—164.9—164.9
Total revenues544.1164.9(20.6)688.4
Expenses
Compensation and benefits
Cash-based compensation and benefits221.9——221.9
Equity-based compensation108.3——108.3
Performance allocations and incentive fee related compensation(72.8)——(72.8)
Total compensation and benefits257.4——257.4
General, administrative and other expenses147.7——147.7
Interest30.8——30.8
Interest and other expenses of Consolidated Funds—139.5(14.9)124.6
Other non-operating expenses0.2——0.2
Total expenses436.1139.5(14.9)560.7
Other loss
Net investment loss of Consolidated Funds—(7.0)—(7.0)
Income before provision for income taxes108.018.4(5.7)120.7
Provision for income taxes21.9——21.9
Net income86.118.4(5.7)98.8
Net income attributable to non-controlling interests in consolidated entities20.5—12.733.2
Net income attributable to The Carlyle Group Inc.$65.6$18.4$(18.4)$65.6
Three Months Ended March 31,
20252024
(Dollars in millions)
Cash flows from operating activities
Net income$150.6$86.1
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization46.945.3
Equity-based compensation103.5108.3
Non-cash performance allocations and incentive fees14.5189.6
Non-cash principal investment income (loss)69.6(68.1)
Other non-cash amounts12.6(2.9)
Purchases of investments(290.9)(215.1)
Proceeds from the sale of investments155.1108.3
Payments of contingent consideration(1.0)(1.5)
Change in deferred taxes, net(29.4)(47.1)
Change in due from affiliates and other receivables12.77.9
Change in deposits and other(10.8)(19.7)
Change in accounts payable, accrued expenses and other liabilities(25.4)41.5
Change in accrued compensation and benefits(327.7)(365.6)
Change in due to affiliates6.5(2.2)
Change in lease right-of-use assets and lease liabilities(2.8)(2.2)
Change in deferred revenue280.2251.6
Net cash provided by operating activities164.2114.2
Cash flows from investing activities
Purchases of fixed assets, net(16.7)(14.2)
Net cash used in investing activities(16.7)(14.2)
Cash flows from financing activities
Payments on CLO borrowings(14.6)(13.9)
Proceeds from CLO borrowings, net of financing costs15.1—
Dividends to common stockholders(126.4)(126.7)
Payment of deferred consideration for Carlyle Holdings units—(68.8)
Contributions from non-controlling interest holders57.762.5
Distributions to non-controlling interest holders(16.9)(19.0)
Common shares repurchased and net share settlement of equity-based awards(176.5)(150.0)
Change in due to/from affiliates financing activities42.356.7
Net cash used in financing activities(219.3)(259.2)
Effect of foreign exchange rate changes4.6(5.0)
Decrease in cash, cash equivalents and restricted cash(67.2)(164.2)
Cash, cash equivalents and restricted cash, beginning of period1,266.51,442.1
Cash, cash equivalents and restricted cash, end of period$1,199.3$1,277.9
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents$1,190.3$1,276.5
Restricted cash9.01.4
Total cash, cash equivalents and restricted cash, end of period$1,199.3$1,277.9
Cash and cash equivalents held at Consolidated Funds$570.9$426.0
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.